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Abstract 
Therapy in modern cardiac electrotherapy is based alrnost 
exclusively on the information about cardiac electrical depolarization. This 
kind of detection lacks any data about the myocardial contraction. An opti­
rnal rhythm control should integrate the assessment of the mechanical 
cardiac activity and related hemodynamic parameters to the already existing 
electrical signal analysis. A hemodynamic sensor integrated in pacing 
would be a valuable instrument for many applications. Only few hemodynam­
ic sensors in cardiac electrotherapy are currently available 
on the market. 
In order to fill the gap, I have explored the possibility of building a hemo­
dynamic sensor for myocardial contraction detection that could be easily 
integrated in the cardiac and defibrillator leads. In this the­
sis I propose two sensors. One is based on tribolectricity and the other one 
requires the measurement of high frequency lead parameters. 
The triboelectric sensor measures the charge due to the 
triboelectric effect between one of the lead conductors and the inserted stylet 
as a result of the lead bending. The measurement system consists in sterile 
charge mnplifiers for use in sterile operation field and a non-sterile enclosure 
containing isolation amplifiers and pavver supply. Atrial and right ventricular 
tensiometric were recorded during numerous ovine and human exper­
iments and have sho\vn good results under different measurement conditions. 
The main downside is the necessity of the additional hardware in ternlS of 
chronic stylet insertion in the lead lumen. 
The sensor based on the Iueasurement of high frequency (HF) pacing 
lead parameters has its origin in previous extensive in vitro experiments 
on the HF characteristics of the lead. These experiments have supported 
the idea of considering any bipolar lead to be a HF translnission line with 
its characteristic impedance and attenuation. An original revaluing 
lead HF parameters after being for more than a decade in the saline 
solution is presented. A parallel on dry new leads was also out. 
The hemodynamic HF sensor is based on the variation of the pacing lead 
3 
HF impedance and reflection coefficient due to its movement during cardiac 
contractions. The quality of the signal \vas proven in a series of ovine and 
hUITwn and during dobutamine test in sheep. 
Both sensors would be heITlOdynarnic sensors for various 
cations: capture managenlent, rate responsiveness, heart failure I1lOnitoring, 
CRT optimization, hemodynamic stability AF ther­
apy titration and syncope prediction. These tvvo sensors are unique 
for their and universality for all existing endovenous bipolar cardiac 
leads. 
Riassunto 
Nei moderni sistemi eli stirnolazione cardiaca, la si basa esclu­
sivamente sull'informazione proveniente dalla elepoladzzazione elettrica del 
rniocardio. Questo metoda tuttavia, non prende in consielerazione Ia compo­
nente meccanica della contrazione del muscolo cardiaco. Un sistema ottimale 
per il controllo dell'attivita cardiaca dovrebbe valutare sia il elettrico 
proveniente cuore sia i parametri emodinarniei correlati aHa contrazione 
del miocardio. Pertanto, un sensore emodinamico nei sistemi di 
stimolazione sarebbe uno strumento utile per vade applicazioni. At­
tualmente suI mercato sono disponibili pochi sensori emodinamici ,nt'Cln',...::. 
nei sistemi eli elettroterapia cardiaca. 
Nel mio progetto di ricerca ho investigato la possibilita eli realizzare 
un sensore emodinamico per la rivelazione delle contrazioni cardiache, che 
potesse essere facilmente integrato esistenti elettrocateteri per la sti­
molazione e elefibrillazione. Ho proposto due sensori. Il prinlO si basa sul­
triboelettrieo, il misura Ie variazioni dei parmnetri degli 
elettroeateteri usati alta frequenza. 
Il primo sensore rileva la cariea generata per effetto triboelettrieo tra 
uno dei eonduttori dell'elettrocatetere e il manelrino a forma di filo h-''--'~u",v. 
eonle eonseguenza della dell' elettroeatetere durante Ie eontrazioni 
del ruiocardio. II sistema di rilevazione e eomposto da amplificatori sigillati 
e sterilizzati per l'utilizzo in campo operatorio sterile. Completa il sistema 
una scatola contenente l'alimentazione e amplificatori isolati, per I'uso al 
eli fuori del eampo sterile. Segnali elettrici sono stati registrati nell'atrio e 
ventricolo eli ovini e urnani, nel corso eli numerosi eseguiti 
in eondizioni diverse. I ottenuti confermano la fattibilita eli questa 
tipo eli sen80re, il eui maggiore svantaggio e rappreselltato dalla neeessita, 
di tenere un ::;upplementare mandrino isolato nelP elettrocatetere impiantato 
cronicamente. 
II sensore basato sulla misurazione dei parametri in alta frequenza elel­
l'elettroeatetere trova sue origini negli sperimenti sulle caratteristiehe in alta 
frequenza dei eateteri considerati come una linea di trasrnissione con un'irn­
f-"'"",-<"'.L.LLiU> caratteristica e Pattenuazione tipica della linea. ::.Iella tesi viene de­
scritto 10 studio comparativo di questi parametri sugli stessi cateteri prima 
e dopo 1a 101'0 irllrllersione nella soluzione fisiologica per pili di dieci anni. 
Inoltre, viene descritto 10 stesso sperimento fatto con 15 nuovi cateteri. 
II secondo sensore proposto si basa sulla misura della variazione dell'im­
pedenza e del coefficiente di dell'elettrocatetere, considerato come 
una linea di trasmissione che viene per effetto delle contrazioni 
miocardio. La buona del segnale ottenuto e stata verificata con vari 
esperimenti condotti su ovini e umani. II sensore e stato anche testato negli 
anirnali in ritmo artificialmente accelerato usando l'infusione di dobutamina. 
Entrambi i sensori proposti potrebbero venire impiegati in molteplici ap­
plicazioni nel campo dell'elettrostirnolazione: adattamento autOInatico della 
corrente di stimolazione, stimolazione antibradicardica con frequenza adatta 
in cronotropicarnente poco efficienti: monitoraggio scompenso 
cardiaco, ottimizzazione della CRT, valutazione della stabilita emodinamica 
della tachicardia ventricolare, adattmnento della terapia per la fibrillazione 
atriale e predizione della sincope neurocardiogenica. I due sensori descritti 
sono unici in termini eli semplicita versatilita, venire 1Il 
tutti elettrocateteri bipolari attualmente presenti suI mercato. 
Chapter 1
Introduction
1.1 Aim of the Thesis
Pacemakers, implantable cardioverter deﬁbrillators (ICD), cardiac resynchro-
nization therapy pacemakers (CRT-P) and cardiac resynchronization therapy
cardioverter deﬁbrillators (CRT-D) are currently delivering therapy based
almost exclusively on myocardial electrical depolarization events. The ﬁnal
scope of the pacing therapy is to provoke myocardial contraction and, even-
tually, to improve the heart pump function. The information based only on
electrical events, does not give the complete insight in the electromechanical
activation of the excitable myocardium. Instead of monitoring the electrical
activity, the real value stands in knowing the outcomes of the pacing stimu-
lus, i.e. the contraction itself. A hemodynamic sensor able to determine the
blood ﬂow or mechanical contraction and integrated in cardiac electrotherapy
systems would be a valuable feature for many applications.
Currently, there are very few commercially available hemodynamic sen-
sors integrated in the pacing system and all of them have some considerable
limitations that do not allow them to be widely used. In order to ﬁll the
existing gap, in this thesis I give few proposals of novel techniques and sen-
sors that might be applied in more or less direct way to the existing pacing
systems. I oﬀer a diﬀerent approach for the solution of the sensor design
problems by applying the knowledge of other ﬁelds of electric engineering,
such as triboelectricity and high-frequency transmission line theory, to the
ﬁeld of cardiac pacing. The ﬁnal aim of my work is to extend the functional-
ity of modern cardiac electrotherapy systems by integrating a hemodynamic
sensor in the existing pacing leads and oﬀer a unique solution for a more
complete patient management. In this way, I want to give a small contribu-
tion in the development of this exciting area of biomedical engineering that
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evolved tremendously during the 60 years of its history.
1.2 Organization of the Report
This report is organized as follows:
In Chapter 1 a short introduction to the problem is given. In Chapter 2 an
introduction to the ﬁeld of cardiac pacing will be carried out together with
familiarizing with some basic notions about hemodynamic sensors integrated
in pacing systems. In Chapter 3 the design of a new triboelectric sensor
for cardiac contractions integrated in the pacing lead will be described. The
ovine and human experiments will be presented together with the analysis
of results. In Chapter 4 the series of acute and chronic measurements of
high frequency parameters of the cardiac leads will be shown. In Chapter 5
a novel sensor for cardiac contractions based on variation of high frequency
parameters of the cardiac lead will be proposed. A detailed report on acute
animal and human experiments will be given. Finally, conclusions and pro-
posals for the future work will be presented in Chapter 6.
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Chapter 2
State of the Art
2.1 Implantable Cardiac Devices
Advances in pacing and deﬁbrillator technology in recent years, supported by
ﬁndings of a large number of well-designed, randomized clinical trials have
resulted in the increasing application of this technology for the treatment
of a variety of cardiac disorders. The result has been a huge increase in the
numbers of devices implanted for tachyarrhythmias and bradyarrhythmias,
as well as heart failure therapy [1]. In fact, already in 2002 there were about
3 million people worldwide with pacemakers [2] and currently around one
million pacemakers are being implanted each year. As newer implantable de-
vices have acquired increasing functionality, interpretation of their operation
has become increasingly progressive. Diﬀerent types of implantable cardiac
devices currently exist in the market and the main distinction is in the type
of therapy they deliver.
A pacemaker is an implantable medical device which periodically delivers
short electrical impulses through the electrodes contacting the heart muscles
in order to regulate the beating of the heart. The primary purpose of a
pacemaker is to maintain an adequate heart rate, either because the heart's
native pacemaker is not fast enough, or there is a block in the heart's electrical
conduction system. These abnormal cardiac rhythms are generally known as
bradycardias.
An implantable cardioverter deﬁbrillator combines a pacemaker and de-
ﬁbrillator in a single implantable device. The purpose of an ICD is to save
lives by treating fast heart rhythms (tachycardias) and lethal ventricular
ﬁbrillation. These types of arrhythmias are treated either by painless an-
titachycardia pacing protocols or by uncomfortable high-voltage electrical
shocks.
9
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Cardiac resynchronization therapy pacemakers and cardiac resynchro-
nization therapy cardioverter deﬁbrillators have multiple electrodes stimu-
lating diﬀerent positions within the heart to improve synchronization of the
lower chambers of the heart and the overall pump function of the cardiac
muscle. They can also oﬀer high-voltage therapies in the case of CRT-Ds.
Figure 2.1: Pacemaker in front of two ICDs (photo courtesy of Medtronic)
2.1.1 Electrophysiology of the Heart
The cardiac cycle is one complete heartbeat. It consists of periods of car-
diac contraction and relaxation, which are controlled by ﬂowing electrical
impulses. During the cardiac cycle, electrical impulses are converted into
mechanical contractions that pump blood out of the heart in a coordinated
sequence. The period of contraction is called systole. The period of relaxation
is diastole. The atria contract when the ventricles relax and relax when the
ventricles contract.
As shown in Figure 2.2, an electrical impulse starts at the sinoatrial (SA)
node, pauses at the atrioventricular (AV) node, then proceeds rapidly along
the conduction pathway to the ventricles. The SA node is at the junction
of the right atrium (RA) and superior vena cava (SVC). It is a cluster of
cells that generates electrical impulses on its own at a rate needed to pump
suﬃcient blood to the body. An electrical impulse proceeds outward from the
SA node, producing a depolarization wave and atrial contraction.
The AV node is in the lower portion of the right atrium, near the ven-
tricular septum. When a depolarization wave reaches this junction, there is
10
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Figure 2.2: Electromechanical activation of the heart (photo courtesy of
Medtronic)
a slight pause. It gives suﬃcient time for a complete ventricular relaxation
and adequate ventricular ﬁlling by an atrial contraction. The delay mecha-
nism ensures atrioventricular synchrony. The His bundle descends into the
ventricular septum, divides into branches, and terminates in Purkinje ﬁbers,
which penetrate the ventricular myocardium. After leaving the atrioventric-
ular node, electrical impulses travel rapidly along these ﬁbers, producing
strong ventricular contractions and the forceful expulsion of blood from the
heart.
An electrocardiogram (ECG) is a record of the electrical activity in the
heart. Electrical impulses are shown as a series of distinct waves in repeating
cycles. The P-wave represents atrial depolarization that is normally converted
to mechanical contraction of the atria. The QRS complex represents ventric-
ular depolarization. The T-wave represents ventricular repolarization that
normally corresponds to ventricular relaxation. Atrial repolarization waves
are small and occur during ventricular depolarization (QRS complex), so
they are usually not seen on an ECG.
The timing intervals such as PR, QRS and QT, shown in Figure 2.3,
are important ECG parameters and the identiﬁcation of electrocardiograms
with prolonged or shortened intervals is of extreme clinical importance. It can
indicate a pathological state that is usually reﬂected in suboptimal cardiac
pump function.
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Figure 2.3: Cardiac cycle timing intervals
2.1.2 Basics of Implantable Cardiac Devices
The most generic cardiac implantable device system consists of a device can
and one or more leads in contact with the myocardium. The electric circuits
delivering and processing the electrical signals are placed in a titanium case
together with a battery in order to protect them from direct contact with
the body tissue and ﬂuids. The can is usually implanted in the left or right
pectoral region. The stimulation pulse generated by the pulse generator is
transferred to the heart by the pacemaker lead introduced into the right
chambers of the heart via the venous system. The pacing pulse enters the
heart via the electrode located at the distal end of the lead. To close the
electric circuit, the stimulation pulse leaves the heart via a counter electrode,
which transfers it back to the source in the pacemaker can. If a unipolar
electrode is used, the device can acts as a counter electrode and if a bipolar
electrode is used, the ring electrode is the counter electrode [3].
The pacemaker is not only able to stimulate the heart muscle. It also
detects the electrical signals produced by the spontaneous cardiac depolar-
ization (sensing). The contraction of depolarized cells in the myocardium
presents as the heart beat. The complete process is called electromechanical
activation of the heart. The sensing of the depolarization signal is achieved
between the tip and ring electrode for bipolar electrodes or between the tip
12
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electrode and pacemaker can for unipolar electrodes. Only if the heart shows
intrinsic activity and the sensing circuitry reveals it correctly, the pacing
pulse is inhibited [3].
Figure 2.4: Triple chamber pacemaker - CRT-P (photo courtesy of Medtronic)
Single chamber systems make use of only one lead, either in the right
atrium (RA) or in the right ventricle (RV). Dual chamber systems with
one lead in RA and another in RV, oﬀer a more sophisticated therapy with
atrioventricular synchrony. As shown in Figure 2.4, triple chamber systems
present an additional lead stimulating the left ventricle (LV) for a syn-
chronous activation of right and left side of the heart in order to optimize
the heart pump function [4].
The vast majority of modern leads are bipolar endovenous leads and they
can have passive or active (screw-in) ﬁxation. There are also diﬀerent forms of
the lead body and we can diﬀerentiate between straight and J-shaped leads.
The latter are normally used for placement in the right atrial appendage
(RAA). The epicardial leads are used only in special cases during cardiac
surgery or in case of venous obstruction. The Figure 2.5 shows a dual chamber
pacemaker with two endovenous bipolar leads with passive ﬁxation. The lead
to the left is an atrial J-shaped lead and the other is a ventricular straight
lead.
There are diﬀerent pacing modes according to the type of the device and
the patient needs. The NBG code given in Table 2.1 describes the pacing
mode - the manner in which the pacemaker paces and senses. The ﬁrst letter
in the NBG code indicates which chambers are paced and the second let-
ter identiﬁes the chambers sensed. The third letter identiﬁes the pacemaker
13
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Figure 2.5: Dual chamber pacemaker with a straight and a J-shaped lead. The
silicone tines close to the cathodes are used for passive ﬁxation (photo courtesy of
Medtronic).
response to sensing. The fourth letter describes programmability and rate
response functionality.
The most common single chamber pacing modes are AAI(R) and
VVI(R). In AAI(R) mode, the pacemaker paces the atrium at the end of
the lower rate interval (corresponds to lower frequency) in the absence of a
sensed atrial event. The pacemaker inhibits the scheduled pacing pulse when
an atrial event is sensed within the lower rate interval. The letter R stands
for the rate responsive mode, the ability to mimic the physiologic need of
faster rhythms during activities. VVI(R) is the analogous pacing mode for
the ventricle.
Dual chamber modes are DDD(R), DDI(R) and VDD. In DDD mode,
the lower rate interval has two portions - an AV interval, which starts with
an atrial event, and a VA interval, which starts with a ventricular event.
The AV interval is the longest period of time allowed before delivery of a
ventricular pace in the absence of a sensed ventricular event. It mimics the
14
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Chamber paced Chamber sensed Response to sensing Programmability
O=None O=None O=None O=None
A=Atrium A=Atrium T=Triggered P=Simple
V=Ventricle V=Ventricle I=Inhibited M=Multiparameter
D=Dual D=Dual D=Dual R=Rate modulation
Table 2.1: NBG pacing mode codes
PR interval - the time between atrial and ventricular depolarization in a
healthy heart. An appropriately programmed AV interval provides suﬃcient
time for a complete atrial contraction and adequate left ventricular ﬁlling,
i.e. it provides AV synchrony. The VA interval is the longest period of time
allowed before the delivery of an atrial pace in the absence of sensed atrial
activity. An example of a DDD pacing with a lower rate of 60 beats per
minute (bpm) is given in Figure 2.6.
Figure 2.6: DDD pacing with a lower rate of 60 bpm (photo courtesy of Medtronic)
In VDD mode, ventricular pacing is synchronized to the sensed atrial
rate up to the programmed upper tracking rate. DDI(R) modes are non-
tracking modes that provide AV sequential pacing at either the lower or
sensor indicated rate. When the atrial rate is faster than the lower rate or
sensor-indicated rate, the patient does not have AV synchrony. Therefore,
only DDD and VDD modes are considered physiological tracking modes.
2.2 Hemodynamic Sensor
The word hemodynamic is derived from the Greek words for blood (haima)
and power (dynamis). Hemodynamics is the study of the movement and
15
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forces of blood. Although cardiac output is probably the most important
parameter to characterize the hemodynamic status of a patient, other pa-
rameters such as ejection fraction, fractional shortening, end-state volumes,
and intracardiac pressures are also used routinely. Because hemodynamics is
the study of blood motion and the forces imposed on the blood, a hemody-
namic sensor can be deﬁned as any sensor that measures either the circulation
of blood or the mechanical action of the heart [5].
Strictly deﬁned, a hemodynamic sensor should directly measure mechani-
cal activity of the heart or blood. By a broader deﬁnition, even an electrogram
signal could be classiﬁed as hemodynamic because the electrical depolariza-
tion of the heart is typically related to the mechanical action. However, as
in the case of electromechanical dissociation, electrical activity might not
be related to mechanical activity and an electrogram could fail to sense a
mechanical response of the heart. A true hemodynamic sensor, therefore,
must directly measure a mechanical parameter and not merely be correlated
with the mechanical response. The ability to measure mechanical action in
the heart or circulation is not the only requirement to implement a hemo-
dynamic sensor in an implanted device: the sensor must also satisfy other
rigorous requirements such as robustness, stability, ease of use, longevity,
and cost. This is not a simple task and many eﬀorts have been put in the
development of the sensors that require custom leads diﬀerent from those
standard and commercially available [5], [6].
Examples of the hemodynamic sensors in electrotherapy systems include
pressure transducers or intracardiac accelerometers. In addition, as technol-
ogy for standard bipolar leads has improved such that many leads last for
the lifetime of the patient, it is expected that these custom leads exhibit
similar longevity and stability: the lead must oﬀer robust measurements for
long periods of time and the sensor outputs need to be stable as they can
often only be calibrated during pulse generator implantation or replacement
procedures or during invasive tests. The sensor also needs to be stable un-
der various patient conditions such as posture changes, exercise, etc. Lastly,
the main stimulus to develop future sensors in bradycardia devices has been
to improve patient therapy while simultaneously decreasing the burden of
physicians to perform additional tests to obtain that therapy improvement.
These tasks are often at odds: adaptive-rate sensors are often patient de-
pendent and require additional testing or time-consuming calibration algo-
rithms to optimize patient therapy. Therefore, whereas hemodynamic sensors
oﬀer great opportunities to improve therapy, these should not be burdensome
to the clinician or the patient. Due to these rigorous requirements, there are
only a few clinically available pacemakers with hemodynamic sensors that
have demonstrated the promise of consistent and acceptable responses [5].
16
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2.2.1 Types of Hemodynamic Sensors
Diﬀerent types of hemodynamic sensors are already implemented in the im-
plantable devices and some are still under investigation. Most of these sensors
cannot be strictly deﬁned as hemodynamic as they only measure parameters
that are in vague relation to the mechanical activity of the heart or blood.
An example are rate response sensors based on patient activity. However, for
sake of better understanding, an overview of this type of sensors will also be
given in the ﬁrst part of this Section.
An activity sensor (piezoelectric or accelerometer) detects body move-
ment and is an indication for patient daily activity. This sensor is normally
used for rate response algorithms in patients with chronotropic incompetence.
It can also indicate to some extent a progressive heart failure with drop of
patient activity. However, this type of correlation depends on the level of ear-
lier activity which is already quite low in the patients with a higher degree of
heart failure. In that case, an activity sensor can hardly be clinically relevant
as the decompensation symptoms would present practically in the same time
[6].
Heart rate variability (HRV) is a measure of autonomic tone; it re-
ﬂects the severity of heart failure and is a marker of prognosis. The de-
vices measure both the short-term and long-term HRV of the intrinsic sinus
rhythm. The 4-week average of the standard deviation of all median atrial-
to-atrial (AA) intervals over 5 minutes has been shown to predict the risk
of death or hospitalization. The advantages of HRV measurement are its
simplicity and minimal battery expenditure. However, it is not applicable in
patients with high burden of atrial tachyarrhythmias or high percentage of
atrial pacing and it is highly dependent on pharmacologic therapy.
The minute ventilation (MV) sensor looks for the number of breaths
per minute and uses it for the rate adaptation algorithms. It is based on
the measurement of the impedance changes across the chest cavity with each
respiration. A sub-threshold signal is sent across the chest between the ring
electrode and the pacemaker can and the change in impedance is measured
between the pacemaker and the tip electrode. The circuitry looks at both
the frequency and the amplitude of the MV signal (relative tidal volume)
to determine the MV count. The strength of MV is a strong correlation to
workload, particularly in and above the sub-maximal levels of workload; the
weakness of the MV sensor is a relatively slow response time - for short
bursts of activity, the MV sensor may be too late to respond. For that rea-
son, it is often integrated with an activity sensor that has complementary
characteristics.
Ventricular repolarization is highly dependent on sympathetic stimula-
17
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tion for both evoked or paced complexes. Therefore, the QT interval might
be used as a physiologic sensor and is usually blended with an activity sensor
for rate response purposes. The longest QT interval has been found to be
positively correlated with the highest cardiac output and the programmed
AV delay. Furthermore, QT interval-determined AV interval also minimized
mitral regurgitation [4] but such an application is not present in the com-
mercially available cardiac devices.
With the onset of heart failure, pulmonary congestion and edema will
set in and contribute to symptoms. Intrathoracic impedance measures
resistivity in the chest, and the impedance will decrease in the presence
of pulmonary ﬂuid [6]. Medtronic algorithm Optivol, based on intrathoracic
impedance measurements, has been shown to detect 76% of the eligible con-
gestive admissions with a median of 17 days of early warning [7]. It enables
clinicians to initiate early medical therapy and potentially reduce or prevent
heart failure hospitalizations. Again the simplicity is a great advantage of
this sensor but its usefulness is limited to the prediction of worsening heart
failure. Likewise the majority of above mentioned sensors, the ﬁeld of applica-
tions of Optivol results to be pretty limited. Hence, it cannot be considered a
complete hemodynamic sensor, especially if applying the narrower deﬁnition
of a hemodynamic sensor being only a blood ﬂow or a myocardial contraction
sensor.
On the other hand, there are some dedicated implantable hemody-
namic monitors (IHM) in the strict meaning of the word hemodynamic.
All of them are designed for long-term monitoring of diﬀerent hemodynamic
parameters. The Chronicle IHM (Medtronic, USA) has the largest amount
of clinical data thus far. It is designed to record ongoing RV pressures, pres-
sure derivatives, heart rate, patient activity and temperature. It consists of a
programmable memory device placed in the pectoral area and a transvenous
electrode carrying a pressure sensor in the RV outﬂow tract as shown in Fig-
ure 2.7. The diagnostic data stored in the device is transmitted via standard
radio-frequency telemetry methods already in place for pacemakers, ICDs
and CRTs. The clinical value of the data recorded by Chronicle is obvious,
especially for heart failure patients [8]. However, it is diﬃcult to justify an
invasive implant procedure of a diagnostic device taking into account possible
perioperative complications.
The majority of above mentioned sensors, IHMs excluded, follow the
broader deﬁnition of the hemodynamic sensor and are not directly propor-
tional to the myocardial contractility. The hemodynamic sensors in the nar-
rowest sense of the word that are directly correlated with the myocardium
contractility or that measure it directly are already implemented in some
commercially available devices:
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Figure 2.7: Chronicle implantable hemodynamic monitor with the lead carrying
the pressure transducer (photo courtesy of Medtronic)
• The Sorin group (Italy) proposed the Peak Endocardial Accelera-
tion (PEA) consisting of a microaccelerometer sensor inside the right
ventricular pacing lead [9]. The system requires a dedicated RV lead
with a special, non-standard connector. The possibility of extending the
system to the right atrium in the case of a dual-chamber pacemaker,
or even to left ventricular pacing lead in the case of CRT, is still under
investigation [10], [11]. However, the limitation of using special leads
remains.
• Some Biotronik (Germany) pacemakers measure the variations of the
unipolar RV impedance during the cardiac cycle since these changes are
related to the modiﬁcation of blood (low impedance) and tissue (high
impedance) contents around the tip of the pacing electrode. During my-
ocardial contraction, the impedance progressively increases reaching its
maximum in late systole. This impedance increase is thought to cor-
relate with right ventricular contractility, and thus, with the inotropic
state of the heart [12], [13]. This system known as Closed-Loop Stim-
ulation (CLS) is currently incorporated in an algorithm for a more
physiological rate modulation used in patients with sick sinus syndrome
(SSS) [14]. It reacts to smaller physiological stresses than conventional
rate adaptive algorithms trying to achieve a heart rate comparable to
that of a normal heart [15], [16].
• Another way of cardiac impedance measurement proposed by Medico
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S.p.A. (Italy) is calledTrans-Valvular Impedance (TVI). TVI mea-
surements are derived between right atrium and ventricle in standard
dual-chamber implants (DDD or VDD) [17]. Diﬀerently from PEA and
CLS sensors which are designed to monitor processes and parameters
correlated to ventricular contraction strength, transvalvular impedance
measurements are more a reﬂection of preload and stroke volume. The
sensor is used for permanent ventricular ejection check after ventric-
ular pacing and sensing, and also for hemodynamic monitoring and
physiological rate modulation.
There were some other ideas that have never been brought to clinical
practice. The best known example is the sensor for the measurement of heart
movements based on ﬁber optics (FOS) proposed by Hoeland and Kloppe
[18], [19]. This investigational device contains an optical ﬁber, with a mirror
at its end, that is inserted into a catheter located in the heart while an
opto-electrical control unit positioned outside the heart contains both the
light source and the signal receiver. The opto-electrical unit generates and
couples the light into the ﬁber and transforms and analyzes the reﬂected
signal that depends on heart movements. Similar to PEA, FOS requires a
special lead and some additional hardware. For that reason and despite its
good performance, the usage of this type of sensor can hardly be extended
to existing pacing systems.
2.2.2 Applications
The aim of modern pacemaker technology is not only to prolong life but also
to provide therapy that is oriented towards the patient's individual needs,
thus improving their quality of life. In the light of that, pacemaker therapy
delivered exclusively on myocardial electrical signal becomes more and more
insuﬃcient. For an optimal and more physiologic control of the heart it would
be extremely important to integrate the electrical signal with an assessment of
the mechanical cardiac activity and of the related hemodynamic parameters.
A hemodynamic sensor integrated in pacing systems would be a valuable
instrument for many applications.
For example, detecting the eﬀective mechanical contraction cycle by cy-
cle is the ultimate way of determining a loss of capture during pacing. The
classical problem of oversensing or undersensing of the electrical depolariza-
tion signals would be also solved by integrating a hemodynamic sensor [20],
[21]. Furthermore, it would be possible to obtain a long term hemodynamic
monitoring of the patient with an early recognition and treatment of decay
in hemodynamic performance of the heart.
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In order to achieve adequate cardiac output in patients with DDD pacing
for a high degree atrioventricular block and in patients with CRT pacing for
advanced congestive heart failure, it is essential to obtain good mechanical
synchronization of the heart chambers [22], [23]. For this purpose, an opti-
mal programming of the paced AV delay and interventricular (VV) delay is
required. A direct assessment of changes in systolic function requires invasive
measurements which are neither practical, nor ethically acceptable as a rou-
tine procedure. For this reason, in clinical practice, the optimization of pacing
therapy is routinely done by echocardiography procedure [24], [25]. However,
this type of procedure can be only performed with the patient supine; it is
extremely time-consuming and operator-dependent. A hemodynamic sensor
integrated in the pacing system that automatically calculates and optimizes
the programmable synchronization parameters, might be an objective mean
of assessing and adjusting therapy, also during activities or exercise [26], [27],
[11].
Another application would be the early detection and therapy delivery
for vasovagal syncope. In fact, a hemodynamic sensor could easily detect
stronger myocardial contractions that precede the vagal reaction.
Hemodynamic stability of the patient varies in diﬀerent types of arrhyth-
mias. A hemodynamic sensor integrated in the detecting system of an ICD
would allow to deliver patient-tailored therapies [28]. For example, in hemo-
dynamically stable patients it would allow to automatically prolong the detec-
tion time and try more sequences of painless antitachycardia pacing therapy.
On the other hand, in unstable patients it would warrant a more aggressive
protocol and less time to the ﬁrst life-saving cardioversion or deﬁbrillation.
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Chapter 3
Triboelectric Sensor
3.1 Introduction
The previous Chapter describes in detail the existing hemodynamic sensors
and their applications in the ﬁeld of cardiac pacing. The majority of these
sensors have some considerable limitations that impede them from being
widely used. They are mostly used for a limited number of applications such
as rate responsiveness. The biggest gap is observable in the ﬁeld of contrac-
tility sensors that are potentially applicable in numerous algorithms. In order
to ﬁll this gap in the pacing therapy, Ferek-Petric [29] proposed a new ten-
siometric sensor integrated in the existing cardiac pacing leads based upon
the triboelectric eﬀect. Later on, I have designed and built the sensor and the
entire measurement system in collaboration with Ferek-Petric. I have thor-
oughly tested the measurement system during acute animal (Section 3.4) and
human experiments (Section 3.5).
The triboelectric eﬀect, more commonly known as electrostatic dis-
charge, occurs when two materials slide against each other. The frictional
force involved in this process causes electrons of one material to separate
and reattach themselves to the second material, creating a charge imbal-
ance between the two surfaces. The induced current in the wiring resulting
from this charge imbalance is responsible for unwanted noise and interfer-
ence in measuring-, controlling-, monitoring- or audio applications. These
disturbances called mechanically induced noises or cable microphony are su-
perimposed to the signals that the cable is carrying. They become more
signiﬁcant in the case of low level signals. The magnitude of the triboelectric
eﬀect, seen in any given wiring, is dependent on the material composition,
humidity, separation rate, frictional forces, and numerous other factors [29],
[30], [31], [32], [33].
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The triboelectric series is a list of materials, starting from materials that
have a greater tendency to attain a positive charge after separation, and
ending with those that have a greater tendency to attain a negative charge
after separation as shown in Table 3.1. Thus, a material towards the negative
end of the triboelectric series, when put in contact with a material closer
to the positive end of the series, will attain a more negative charge, and
vice versa. More distant are two materials from each other on the series,
greater is the transferred charge [30], [31], [32], [33]. A generalized equation
for the current induced between any two materials can be expressed with the
following equation [34]:
i =
k ·M · vn
D
+Q · C · M
D
(3.1)
where k is a proportionality constant unique to material, M is mass ﬂow
rate, D is average particle diameter, v is particulate velocity, n is the expo-
nent unique to material, Q is the charge on contacting particles, and C is a
proportionality constant.
As evident from this relationship, many of the proportionality con-
stants have been obtained empirically. Furthermore, this relationship may
be straightforward in applying to simple theoretical situations such as a sin-
gle particle running along a surface, but it may prove diﬃcult to apply to
more complicated problems.
Applying the triboelectric eﬀect in the ﬁeld of cardiac pacing may give
an opportunity to detect cardiac pacing lead movements due to the cardiac
contractions. In fact, ﬂexed or otherwise deformed cardiac pacing leads seen
as coaxial or parallel cables, may also generate electrical noise. I have con-
structed a measurement system able to quantify this noise, i.e. the charge
created between diﬀerent pairs of conductors. The system has also been tested
for charge measurements between one of the pacing lead conductors and a
pacing lead stylet that is normally inserted in the internal lumen of the lead
only during a regular implant procedure in order to provide additional stiﬀ-
ness and support for the lead placement. In this case, instead of a classic
stylet made of wire, I used diﬀerent kinds of isolated wires made of diﬀerent
materials in the eﬀort to obtain better signal. I have thoroughly tested the
instrumentation in acute animal and human studies [35], [36].
3.2 Sensor Design
In order to measure the charge created between the lead stylet and one of
the conductors, a charge ampliﬁer was designed. This was a modiﬁed circuit
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Most positive
Air
+++
Human Hands, Skin
Asbestos
Rabbit Fur
Glass
Human Hair
+
Mica
Nylon
Wool
Lead
Cat Fur
Silk
Aluminum
Paper
Cotton
Steel
-
Wood
Lucite
Sealing Wax
Amber
Rubber Balloon
Hard Rubber
Mylar
Nickel
Copper
Silver
Brass
Synthetic Rubber
Gold, Platinum
Sulfur
Acetate, Rayon
Polyester
Celluloid
Polystyrene
Orlon, Acrylic
Cellophane Tape
- - -
Polyvinylidene chloride (Saran)
Polyurethane
Polyethylene
Polypropylene
Polyvinylchloride (Vinyl)
Kel-F (PCTFE)
Silicon
Teﬂon
Silicone Rubber
Most negative
Table 3.1: Triboelectric series
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of a previously designed ampliﬁer [37] for the measurement of the electric
charge created within the electrodes of the special lead for tricuspid blood
ﬂow sensing. The new ampliﬁer had a charge gain of 4.5 · 109 in the band
between 1.6 Hz and 16 Hz. A guard drive ampliﬁer was also added for a
better signal-to-noise ratio.
The measurement ampliﬁer was divided in two parts: an isolation ampli-
ﬁer stage comprising isolation power supply, and a diﬀerential charge pream-
pliﬁer that could be sterilized and applied within the surgical ﬁeld. A pair
of electrometer ampliﬁers has been used at the input of the charge ampliﬁer:
Burr-Brown OPA 128 or lately Analog Devices AD 549 due to the unavail-
ability of the former type. The input resistances were selected to the available
low-noise 100 MΩ (RS Electronics, US) value that yields the low-pass ﬁlter-
ing at 16 Hz (-3dB). The high-pass ﬁltering is 1.6 Hz (-3dB) with the selected
feedback components of 100 pF and 1 GΩ. Ampliﬁers Burr Brown INA105
were used for both the diﬀerential output stage and the guard ampliﬁer.
Zener diodes protect the input from electrosurgery and static potential. The
output signal from the diﬀerential ampliﬁer is led via 2 m long patient cable
to the input of the isolation ampliﬁers Burr-Brown ISO 121. Decoupling ca-
pacitor of 4.7 µF yields lower cut-oﬀ at the frequency of 0.17 Hz preventing
the baseline shift due to the stray charges which may accumulate on the feed-
back capacitor. Quadruple isolating DC/DC converter Burr-Brown 724 was
used for the symmetric voltage isolated power supply. The complete circuit
diagram is shown in Figure 3.1.
The elements were soldered on the printed circuit boards (PCB) pro-
duced manually and the pre-ampliﬁers were mounted within the plastic case
as shown in Figure 3.2. The logic of the standard pacemaker system analyzer
(PSA) connection was used whereby black alligator is for the lead connector
pin connection and red alligator for either the skin or the connector ring con-
nection. White alligator was used for connection of the stylet. Fisher medical
grade 4-wires cable with 9 mm circular connector attached (RS Electronics,
USA) is used to conduct the positive and negative supply, output signal and
ground.
Isolation ampliﬁers having the gain of 10 and an isolated DC/DC con-
verter were soldered onto the PCB. They were mounted into the steel enclo-
sure (Figure 3.3) having two input connectors for the patient cable bringing
signal from the charge ampliﬁers and two BNC output connectors. The Ni-Cd
9,6 Volts battery (not shown) was mounted on the top of the circuit. Circuit
diagram does not show the 100 nF ceramic capacitors and 5 µF tantalum ca-
pacitors used for power supply decoupling ﬁlters keeping power supply noise
from entering the circuit. Finally, six pre-ampliﬁers and one dual channel
isolation box were produced.
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Figure 3.1: Charge ampliﬁer and isolation ampliﬁer circuit design
Figure 3.2: Preampliﬁer box
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Figure 3.3: Isolation ampliﬁers and the DC/DC converter mounted within the
enclosure
3.3 Measurement Setup
Each of the six pre-ampliﬁer enclosures has two short alligator clips protrud-
ing out of the box for input connections of the charge ampliﬁer and the third
for the guard drive skin connection. The pre-ampliﬁer boxes were sterilized
before their usage in the operative sterile ﬁeld next to the pacing lead in-
sertion position in the right pectoral region of the patient (Figure 3.4). This
position helped in minimizing the noise that would have been created on
longer connection cables as well as in improving the simulation of the real
situation in which the sensor circuit would be contained in an implantable
device normally placed in the very same region of the thorax.
The sterile enclosure was connected via a long sterile patient cable to the
non-sterile dual channel isolation box. The output signal of the isolation box
was sent via a coaxial cable towards the National Instruments connector block
and further to the PCMCIA acquisition card (DAQCard-6024E, National
Instruments, USA) inserted in Precision M6400 mobile workstation (Dell,
USA).
The patient ECG cable was connected to the 2090 CareLink pacemaker
programmer (Medtronic, USA) and the signal was acquired to the laptop
via the analog input/output box (2090AB, Medtronic, USA) using the same
28
3.3. MEASUREMENT SETUP
Figure 3.4: Preampliﬁers ready for package sealing and ethylene-oxide sterilization
DAQCard. In the animal experiments, I also acquired the ventricular elec-
trogram (VEGM) signal brought to the 2290 analyzer block of the CareLink
programmer via the patient cable connected to the lead connector in the
standard way. The VEGM signal was sent to 6024E in the same way as the
ECG signal. Figure 3.5 illustrates the block diagram of the entire measure-
ment system. The process of waveform acquisition via DAQCard-6024E was
programmed using LabView 2009 SP1 software (National Instruments, USA)
and the numerical data were saved into Excel sheets (Microsoft Oﬃce, Mi-
crosoft, USA) for further processing and graphic presentation. If necessary,
moving average trendline was superimposed on the noisy signal waveform for
better visualization.
The stylet wire selection was guided by mechanical properties of axial
rigidity for easier insertion and radial ﬂexibility for better signal. I have
prepared 3 kinds of wires having diameters between 0.012" and 0.016". One
was polytetraﬂuoroethylene (PTFE) coated single strand steel wire (Belden
Inc., USA), the second was a nylon coated 7-strand steel wire (Surﬂonr,
American Fishing Wire - AFW, USA) and the third was also a nylon coated
7-strand steel wire from a diﬀerent manufacturer (Cormoran, Germany). The
wires were cut to the length of the lead and insulated at the distal tip by
the lacquer, while the insulation was grinded of the proximal tip for proper
connection with the alligator clip.
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Figure 3.5: Triboelectric sensor - measurement setup
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3.4 Acute Animal Experiments
3.4.1 Methods and Materials
The acute animal experiments have been performed at the Faculty of Vet-
erinary Medicine in Zagreb, Croatia, in collaboration with a cardiologist as
implanting physician and two veterinarians. The measurement system was
tested in eight sheep (42 ± 6 kg) at baseline and during acute hemodynamic
interventions: dobutamine infusion up to 15 µg/kg/min. The goal was to
achieve a heart rate of minimum 160 beats/minute and not to exceed 220
beats/minute.
After premedication with xylazine (0.1 mg/kg), ketamine (5 mg/kg) and
butorphanol (0.1 mg/kg) we proceeded to oral intubation. General anesthe-
sia was inducted with sodium thiopenthal (5-10 mg/kg) and maintained with
sevoﬂourane using the S/5 Aespire anesthesia delivery system (GE Health-
care, UK).
Three diﬀerent types of custom-made leads have been implanted in the
sheep. The ﬁrst one was a modiﬁed ICD lead, the second was a two-dot
tricuspid valve ﬂow velocity measurement lead and the third type was a
6-ring blood-ﬂow sensor lead.
In ﬁve sheep we have implanted the custom-made ICD lead shown in
Figure 3.6. It is a modiﬁed Sprint Quattro Secure S 6935 active-ﬁxation
single-coil ICD lead (Medtronic, USA). A standard 7x7 lead conductor (7
bundles of 7 wires) made of MP35N nickel alloy was inserted into the other-
wise empty lead body lumen used for the second high-voltage (HV) cable in a
dual-coil lead. The 7x7 conductor was inserted as far as possible towards the
distal portion of the right ventricular coil electrode. A standard DF-1 con-
nector was attached on the proximal end of the cable obtaining a connection
for the dead-end isolated conductor.
In two sheep we have implanted the custom-made 2-microdot electrodes
lead designed for measurement of tricuspid blood ﬂow. It is a straight silicone
lead with 2 internal wires connected to the respective platinum dots having
diameter 1 µm positioned on the surface of the epoxy bead. The epoxy bead
is placed on the lead body in the position to be within the tricuspid valve
when the tip is within the apex (Figure 3.7).
In one sheep we have implanted the custom-made six-ring lead originally
designed for measurement of blood ﬂow (Figure 3.8). Each electrode has its
own proximal connector which made possible the testing of diﬀerent mea-
surement vectors. There is a mutual distance of 10 mm between the ring
electrodes.
The lead insertion was done through the left jugular vein using a 9 or 10
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Figure 3.6: Custom-made ICD lead used for animal experiments. White arrow
points to the RV high-voltage coil. Looking from left to right, the connectors belong
to the RV coil, the pace/sense conductor and the dead-end conductor normally used
for SVC HV coil in dual-coil leads.
Figure 3.7: Custom-made 2-microdot electrodes lead for tricuspid ﬂow measure-
ment. (1) - connectors for wires leading to the platinum dots (3) positioned in the
tricuspid valve; (2) - connector for the dead-end lead.
French (Fr) lead introducer (Medtronic Solo-Trak PLI) in ﬁve animals with
ICD leads or by direct venous cut-down in the remaining three sheep. The
leads were positioned in the apex of the right ventricle using ﬂuoroscopy. Five
custom-made ICD leads were screwed in the RV apex, while the custom-made
six-ring electrode lead had a passive ﬁxation system. Two-dot leads did not
have a dedicated ﬁxation system. The epoxy bead was ﬂoating rather freely
in the ventricle within the tricuspid valve as the tip of the lead has been
advanced into the RV apex.
32
3.4. ACUTE ANIMAL EXPERIMENTS
Figure 3.8: Custom-made 6-ring lead used for animal experiments. The tip is
positioned in RV apex. The ring electrodes are equally spaced and positioned in
RA and in the tricuspid valve.
3.4.2 Results
The ﬁrst ﬁve acute ovine experiments have been performed using the custom-
made ICD lead and I have measured the signal between diﬀerent triboelectric
pairs.
The best results were obtained between the pace/sense coil conductor and
the specially added 7x7 dead-end conductor. In this case, the materials in-
cluded in the triboelectric series are MP35N nickel alloy for both conductors,
PTFE as a redundant coating for the coil conductor and the inner silicone
insulation forming the lead body [38]. Silicone and Teﬂon are considered very
negative in the triboelectric series and, as such, are very distant from nickel
that is also positioned in the negative series but much closer to the materi-
als with no charge. The distance in the triboelectric series ensures a bigger
charge transfer between the materials and, consequently, better signal in the
triboelectric sensor (TBS). Figures 3.9 and 3.10 show the triboelectric sensor
signal (TS), ECG and intracardiac electrogram (EGM) obtained in the same
sheep in sinus rhythm with 105 beats/minute (bpm) and during dobutamine
infusion with 195 bpm. The peak-to-peak amplitude of the triboelectric sig-
nal was around 1.5 V for sinus rhythm and 2.5 V during the accelerated
rhythm which corresponds, respectively, to the charge of 333 picoCoulombs
33
CHAPTER 3. TRIBOELECTRIC SENSOR
peak-to-peak (pCpp) and 555 pCpp.
Figure 3.9: Triboelectric signal acquired during sinus rhythm (around 105 bpm)
between the pace/sense conductor and the dead-end conductor.
Power spectral density (PSD) of TS between the pace/sense conductor
and the dead-end lead was computed for 32 seconds long sequences in all 5
sheep both in sinus rhythm and during the accelerated rhythm (Figure 3.11).
The frequency was normalized (fnorm) to the fundamental ECG frequency,
i.e. to the heart rate during each of the recorded sequences. Most of the
power is condensed around the fundamental ECG frequency and its multiples.
After the third multiple, PSD amplitudes drop quickly towards extremely low
values.
The peak values of PSD at fnorm = 1 vary from 8.5 to 541 W/Hz be-
tween sequences with no correlation to the contractility, i.e. the dobutamine
infusion. For a better visualization, PSD values in the graph are shown nor-
malized to the peak value obtained at fnorm = 1.
TS frequency content is highly correlated to the ECG frequency spectrum
and is representative of myocardial contractions. Taking into account that
the highest expected heart rates are around 300 bpm which corresponds to
the ECG frequency of 5 Hz and knowing that PSD is very low after its
third multiple, we can conclude that the low-pass cut-oﬀ of the measurement
system at 16 Hz is adequate for this type of measurements.
The signal amplitude was much smaller when measured between the
pace/sense coil conductor and a custom-made stylet in coaxial arrangement.
I have used two types of stylets: Surﬂon by AFW and nylon-coated by Cor-
moran. The waveforms obtained with Surﬂon stylet were achieving maximum
level of 50 mV peak-to-peak and in the case of nylon these values were some-
what bigger up to 80 mV as shown in Figure 3.12. A very small increase
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Figure 3.10: Triboelectric signal acquired during dobutamine infusion (around
195 bpm) between the pace/sense conductor and the dead-end conductor.
Figure 3.11: Power spectral density for sequences obtained between the
pace/sense conductor and the dead-end conductor of the ICD lead.
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in the signal amplitude was recorded after the dobutamine infusion. These
signals were an order of magnitude below the signals obtained between two
parallel conductors.
Figure 3.12: Triboelectric signal measured between the pace/sense coil conductor
and the nylon-coated stylet with the moving average trendline superimposed.
The 6-ring lead was used for measurements in diﬀerent conﬁgurations.
I measured the triboelectric signal in the coaxial arrangement between the
Surﬂon stylet and the pace/sense coil conductor. The parallel conﬁguration
was tested between the Surﬂon stylet and each of the six electrodes separately.
The Figure 3.13 shows the introduction of the stylet in the lumen of the
bipolar pace/sense conductor. The remaining six connectors belong to the
ring electrodes.
The signal measured in parallel conﬁguration has never exceeded 100
mV. Nevertheless, the waveform is clearly depicting the heart contraction as
shown in Figure 3.14. In this case, I was able to acquire two EGM channels
simultaneously. One channel was the ventricular unipolar EGM. The other
EGM signal was acquired between the two most proximal ring electrodes that
were positioned in the lower right atrium (AEGM) showing both atrial and
ventricular depolarization. Comparing the electrograms, it is clear that TS
depends on ventricular contraction only. Similar results but with somewhat
smaller signal were obtained during the measurement between the same stylet
and the pace/sense conductor.
The TS in the custom-made 2-dot electrodes lead was measured between
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Figure 3.13: The implanter is introducing the stylet in the lumen of the pace/sense
conductor of the 6-ring lead. The remaining six connectors belong to the ring
electrodes.
Figure 3.14: Triboelectric signal in the 6-ring lead measured between the Surﬂon
stylet and the conductor belonging to the middle 3rd ring electrode. The moving
average trendline is superimposed.
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one of the conductors connected to the dot on the epoxy bead and the dead-
end conductor. The signal was clearly representing the ventricular contraction
but its amplitude was an order of magnitude lower compared to the signal
measured in the 6-ring lead.
In spite of smaller amplitudes of TS measured using the stylet compared
to the case of TS acquired between the pace/sense conductor and the dead-
end conductor in the ICD leads, the frequency content was pretty much the
same in all sequences. As expected, PSD peak values were much smaller in
the case of stylets and were all in the range between 1 and 80 mW/Hz.
In most of the cases, there was no need to additionally ﬁlter the acquired
signal as the waveforms were clear. However, in some cases the waveforms
were not recognizable at all due to a very low signal-to-noise ratio. The worst
case is shown in Fig. 3.15. This waveform was acquired between the nylon
stylet and the pace/sense conductor of the ICD lead with a very low peak-
to-peak amplitude and the noise completely masking the signal. I calculated
the FFT of the signal and used a selected subset of the frequencies between 1
and 6 Hz for signal reconstruction that resulted in a waveform representative
of myocardial contractions. In this case, SNR was -7.5 dB as the signal power
was very low. Nevertheless, by simple ﬁltering which is ordinarily done for
EGM signals in the implantable devices, I was able to obtain the signal that
was good enough for the ﬁnal purpose of contraction detection. In more
favorable cases, it was even not necessary to ﬁlter the signal for successful
contraction detection and SNR exceeded 30 dB.
3.5 Acute Human Experiments
3.5.1 Methods and Materials
The acute human experiments have been performed using the standard pac-
ing leads during regular primary implantations or replacements of pacemak-
ers and ICDs under local anesthesia. Therefore, I acquired the triboelectric
sensor signal in both newly implanted leads and chronically positioned leads.
All measurements prolonged the normal testing procedure for maximum 10
minutes. The measurement system was tested in 18 patients at baseline and
during paced rhythms. I was able to observe the sensor response in diﬀerent
underlying rhythms - atrial ﬁbrillation (AF) with bradyarrhythmia, atrioven-
tricular blocks of diﬀerent grades, and sinus bradycardia. The measurement
setup was identical to the animal studies and is thoroughly described in Sec-
tion 3.4.1.
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Figure 3.15: The original signal is masked by strong noise. Reconstructed signal
after ﬁltering is good enough for a successful contraction detection.
3.5.2 Results
As expected, PSD of all sequences obtained during human experiments was
concentrated around the fundamental ECG frequency, analogously to the
ovine measurements. The signal amplitude was comparable to the stylet mea-
surements in sheep and was always between 5 and 100 mV peak-to-peak which
corresponds to charges between 1.1 and 22.2 pCpp. Diﬀerent types of stylets
have not yielded statistically signiﬁcant diﬀerence in signal amplitudes. How-
ever, I noted a trend towards higher amplitudes for the measurements with
Surﬂon stylet, although I should conﬁrm these ﬁndings with further experi-
ments in a larger number of patients.
This section brings the most interesting cases that describe the ﬂexibility
and capability of the triboelectric sensor in most diﬀerent clinical cases.
Patient was referred for dual chamber DDD pacemaker implantation due
to the syncope, intermittent total AV block and an extreme permanent 1st
degree AV block. The lead position was standard: ventricular CapSure Z
Novus 5054 (Medtronic, USA) in the RV apex and atrial CapSure Z Novus
5554 (Medtronic, USA) in the RA appendage. Two tensiometric stylets made
of Cormoran nylon 7-strand 0.012" steel wire were introduced in both leads.
Three-channel recording was done: ECG, atrial TS and ventricular TS. As
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the waveforms were relatively clear, the signals were not ﬁltered and only
the moving average trendline was added within the Excel chart for easier
interpretation. Figure 3.16 shows that the atrial waveform had much lower
amplitude relatively to the ventricular. This is obviously due to the lower
magnitude of the lead bending, a result consistently conﬁrmed throughout
the experiment on other patients.
Figure 3.16: Triboelectric signal measured in atrial (ATS) and ventricular (VTS)
channel using the nylon stylets.
A male underwent the implantation of the single lead VDD pacing system
due to the intermittent total AV block and permanent 2nd degree AV block.
The Medtronic lead CapSure VDD-2 5038, having 13.5 cm interelectrode dis-
tance was implanted. Figure 3.17 discloses ECG and TS which exhibits three
major waves. The ﬁrst one is due to the atrial contraction that follows the P
wave. The second wave corresponds to the ventricular contraction following
the QRS wave. The third one has the largest amplitude and follows the P
wave that is not conducted to the ventricle. Comparing the signal to the
ﬂuoroscopy movie, I concluded that the lead bending in the non-conducted
atrial contraction has greater amplitude than during the conducted atrial
contraction followed by the ventricular contraction. This is due to a less
constricted movement of the lead in case of absence of the ventricular con-
traction. In that situation the lead exhibits a complete displacement without
being pulled back by the ventricular contraction.
Implantation of a dual chamber pacemaker was done. Figure 3.18 shows
the oscilloscope measurements (Waverunner LT342, LeCroy, USA) for the
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Figure 3.17: AV block Mobitz 2nd degree. Triboelectric signal in the VDD lead
with the nylon-stylet. Non-conducted P-waves produce larger triboelectric signals
compared to conducted atrial depolarization.
passive ventricular lead CapSure Z Novus 5054 (Medtronic, USA) positioned
within the RV apex. The patient was in supraventricular tachycardia. The
negative slope of the tensiometric signal was caused by the contraction and
consequent bending of the lead, while the positive slope of the tensiometric
signal was caused by the relaxation and consequent elongation of the lead.
Similar to the previous case, a shorter coupling interval causes the decrease of
TS amplitude due to the lower magnitude of the lead bending and vice versa
for longer coupling intervals. Electromechanical dissociation is demonstrated
in Figure 3.19 wherein the fourth QRS complex is not followed by the cardiac
contraction. The seventh QRS complex has a very short coupling interval that
results in signiﬁcant contraction impairment with small TS amplitude.
Another patient underwent an implantation of a ventricular lead. In this
case, a Belden PTFE coated wire was inserted in the stylet channel but
it was too short to be inserted distally until the lead tip implanted within
the ventricular apex. As shown in Figure 3.20, TS exhibits two waves, one
caused by the atrial contraction and the other caused by the ventricular
contraction. This is obviously another characteristic of the sensor that could
markedly improve the proposed method of AV interval regulation utilizing the
Peak Endocardial Acceleration (PEA) sensor [27]. However, the amplitude
of TS was much smaller compared to the case of the sensor in ventricular
position. As in the cases described above, it is most probably due to a smaller
magnitude of the lead bending in the region where the stylet was positioned.
A patient had a bipolar temporary lead urgently implanted and connected
to an external pacemaker due to the syncope. Successively, she has under-
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Figure 3.18: Shorter coupling interval causes the decrease of TS amplitude.
Figure 3.19: Electromechanical dissociation at the 4th QRS complex and the
decrease of TS amplitude in a shorter coupling interval after the 6th QRS complex.
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Figure 3.20: Shorter stylet in the ventricular lead results in triboelectric signal
representing both atrial and ventricular contraction.
Figure 3.21: TS measured between the PTFE Belden wire used as stylet and the
inner conductor of the ventricular pacing lead.
gone the implantation of the bipolar ventricular lead. Figure 3.21 shows the
bradycardia with AF at 48 bpm and TS between the PTFE coated Belden
stylet and the inner coil of the lead. There was almost no diﬀerence in sig-
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Figure 3.22: TS signal during pacing has a much diﬀerent morphology compared
to the sinus rhythm. Loss of capture was correctly identiﬁed after the 3rd QRS
complex.
nal when the ampliﬁer's input was connected to the outer conductor of the
coaxial bipolar lead. As expected, paced QRS complexes in Figure 3.22 have
a signiﬁcantly diﬀerent morphology on the ECG trace compared to sinus
rhythm in previous traces. A diﬀerent contraction pattern, following a post-
pacing depolarization propagating from the RV apex, results in a completely
diﬀerent TS showing its sensitivity to diﬀerent contraction course. Successive
decrease of the pacing current caused intermittent capture. Loss of capture
occurs after the fourth spike in Figure 3.22. There is no TS wave after the
loss of capture event. In this case, the signal was recorded between the stylet
and the outer coil of the bipolar lead.
3.6 Conclusions and Possible Extensions
The above described experiments proved that the triboelectric sensor func-
tions acutely in humans and in animals and that it functions in chronically
implanted leads in humans. In the ovine experiments, the stylets have been
left in the implanted leads for chronic evaluation of the sensor. Next mea-
surements in sheep are scheduled after four months and after one year, in
order to evaluate the long term stability of the sensor.
In most of the cases, the deﬂection of the ventricular lead occurred in
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its distal portion at the curvature within the tricuspid valve. Cardiac con-
tractions pulled the right ventricular segment of the lead in cranial direction
thereby ﬂexing the tricuspid and low atrial segments of the lead. Diﬀerent
positions of the lead tip implantation yielded diﬀerent lead deﬂection and
diﬀerent signal magnitude. Periodic variation of the tensiometric signal ex-
actly corresponds to the periodic variation of the bending curve of the lead
within the right ventricle.
In the future experiments, I will have to correlate the bending curve geom-
etry change on the ﬂuoroscopy with the sensor's signal waveform as diﬀerent
anatomic positions of the lead tip yield diﬀerent TS waveforms. The sensor
may deﬁnitively be used in capture management and tachycardia detection
algorithms. If it reveals the long-term stability, it will also be feasible for CRT
hemodynamic optimization and heart failure monitoring. Its clinical utility
may be extended to rate responsive pacing and vasovagal syncope prediction
algorithms.
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Chapter 4
High Frequency Parameters of
Pacing Leads
4.1 Introduction
The majority of the existing hemodynamic sensors requires a special lead or
the considerable amount of additional hardware. This impedes the sensors to
be widely used in existing pacing systems. In order to overcome the problem
concerning the building of speciﬁc leads, Ferek-Petric proposed a universal
hemodynamic sensor based on high-frequency (HF) properties of the pacing
lead seen as a transmission line [39].
The myocardial contraction causes the lead to bend. The ﬂexion of the
lead immediately changes its geometry and impedance. An accurate mea-
surement of the HF impedance or any other characteristic dependent on HF
impedance such as reﬂection or transmission coeﬃcient, can precisely de-
scribe the cardiac contraction. In vitro experiments conducted by our group
showed that such measurements can be easily performed on any cardiac lead
having at least two conductors that are parallel, helicoidal (co-radial) or coax-
ial. The main concern is the chronic stability of the HF characteristics in the
hostile environment constituted of human body and its liquids.
The ﬁrst step in the study consisted in the measurement of the propaga-
tion speed of the signal in the range of 1-21 MHz within the cardiac lead.
This ﬁrst phase also consisted in the measurement of HF characteristics such
as impedance and attenuation coeﬃcient of unused dry leads [37], [40]. After
the measurements, the leads have been immersed in saline solution for more
than 10 years simulating the human body environment.
I repeated the experiments subsequently to the lead extraction from the
physiologic solution. I wanted to determine the type and amount of chronic
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alterations in the lead structure observable in terms of variation of their HF
characteristics. I have also measured the same physical quantities in a number
of dry new pacing leads in order to compare their HF characteristics to those
pertinent to the old leads [40]. These new leads will also be immersed in
saline for some time. The alterations due to the penetration of the physiologic
solution will need to be revalued at the end of that period.
4.1.1 Transmission Line
An electrical lead can transmit electrical signals at high speed which can
approach large fractions of the speed of light. If the length of the lead at
high frequency signals becomes comparable to the wavelength, the lead can be
considered electrically long. In such a case the lead can not be described with
lumped parameters, but must be considered as a transmission line with its
characteristic impedance. The wavelength λ (m) for a lead can be calculated
as:
λ =
v
f
(4.1)
where v (m/s) is the propagation speed of the wave in the transmission line
and f (Hz) is the frequency of the signal [37].
The transmission line impedance at a particular frequency is deﬁned as
the ratio between voltage and current of both forward and reﬂected wave at
the same frequency. The sending-end impedance is deﬁned as
Z = Z0 · ZR + Z0 · tanh(γ · d)
Z0 + ZR · tanh(γ · d) (4.2)
where Z0 is the characteristic impedance of the line of length d, ZR is the
receiving-end load impedance and the propagation constant γ is a measure
of the change undergone by the amplitude of the wave as it propagates in
a given direction. The constant γ depends on the ratio between transmitted
and incident wave voltages and it can be deﬁned for any point x along the
transmission line [41]:
Vtransmitted
Vincident
= e−γ·x = e−(α+jβ)·x (4.3)
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The real part α of the propagation constant corresponds to the attenuation
coeﬃcient expressed in Neper/meter (Np/m) that describes the rate of atten-
uation of the propagation wave on a lossy transmission line. The imaginary
part of γ is the phase constant β that reﬂects the wave nature of a high-
frequency wave along the transmission line with its maxima and minima
[42]. The impedance of a line long d meters in open and short termination is
obtained from 4.2 considering ZR equal to inﬁnity for an open line or equal
to zero for a short termination:
Zopen =
Z0
tanh(γ · d) (4.4)
Zshort = Z0 · tanh(γ · d) (4.5)
The characteristic impedance Z0 can be easily obtained from previous equa-
tions 4.4 and 4.5:
Z0 =
√
Zopen · Zshort (4.6)
Accordingly, propagation constant γ is obtained from
tanh(γ · d) =
√
Zshort
Zopen
(4.7)
4.2 Previous Acute Experiments
The ﬁrst experiments carried out by Ferek-Petric [37] consisted in measuring
the propagation time of the wave at the frequency of 20 MHz in 3 cardiac
pacing leads with diﬀerent geometries and insulation materials (Table 4.1):
• Medtronic coax sil is a coaxial bipolar conductor of a pacing lead with
silicone insulation produced by Medtronic, USA.
• Cordis coax poly is a coaxial bipolar lead conductor with polyurethane
insulation by Cordis, USA.
• Medtronic twin silicone is a silicone lead with parallel conductors.
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Lead Insulation Propagation
speed (m/s)
Wavelength
(m)
Length/
Wavelength
Medtronic coax sil Silicone 71.4 · 106 3.57 0.15
Medtronic twin sil Silicone 56 · 106 2.80 0.20
Cordis coax poly Polyurethane 45 · 106 2.25 0.28
Table 4.1: Propagation speed measurement results for silicone and polyurethane
leads
The wavelength values at 20 MHz for each of the leads were obtained using
equation 4.1. The measurements showed that there is a signiﬁcant diﬀerence
between diﬀerent types of leads. The polyurethane lead has a lower propa-
gation speed than the silicone leads. The polyurethane lead has an electrical
length for 20 MHz of more than a quarter wavelength. The silicone leads have
a faster propagation speed, but are still relatively electrically long with a ratio
of lead length and the corresponding wavelength at 20 MHz between 0.15 and
0.2. These results conﬁrm that the frequency range up to 20 MHz is appro-
priate for future measurements of HF characteristics of the pacing leads. This
would be the maximum frequency used in ultrasonic sensor applications and
it is lower than frequencies used by major commercial broadcasting services
thereby preventing interference.
More than ten years ago, Ferek-Petric has also conducted a series of
impedance measurements on 7 cardiac leads with diﬀerent geometries of the
conductors and with diﬀerent materials used as insulation in order to deter-
mine their characteristic impedances and attenuation coeﬃcients. In this ﬁrst
phase, he analyzed two coaxial Medtronic leads with polyurethane 80A insu-
lation (4004M CapSure and 6990U Spectraﬂex), Cordis Encor polyurethane
coaxial lead, Medtronic parallel silicone lead (model 6901), home-made Gore
insulated twin pair, and two prototype silicone insulated leads: a quadripolar
lead with parallel conductors and a 4-ﬁlar co-radial lead with inner Teﬂon
insulation. All measurements have been done in the frequency range of in-
terest between 1 and 21 MHz. After the experiments, all 7 leads were put in
the saline solution for more than a decade in order to simulate the chronic
situation of the human body.
4.3 Latest Acute and Chronic Experiments
4.3.1 Materials and Methods
Although the leads have been kept in the saline solution for more than 10
years, all except one were intact after the extraction. Only the polyurethane
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Spectraﬂex lead was visibly corroded. This was most probably due to the
chemical process of metal ion oxidation (MIO) typical for polyurethane insu-
lated leads. In fact, a metal ion that comes in contact with body ﬂuids and
the polyurethane, catalyzes an oxidative chemical degradation of the insula-
tion material. This has caused a lot of unexpected lead failures in the ﬁrst
years after the introduction of polyurethane as an insulation material.
In order to revalue the characteristic impedances and the attenuation co-
eﬃcients in the same frequency range from 1 MHz to 21 MHz for these 7
leads, I used a network analyzer (3577B, Hewlett-Packard, USA) in combi-
nation with the 35676B Reﬂection/Transmission Test Kit (Hewlett-Packard,
USA). The measurement data were uploaded to a laptop through the GPIB
interface of the network analyzer and using the National Instruments GPIB
Express Card. The programming code for the upload of measured data was
written in Matlab software (MathWorks, USA) and the data were saved into
Excel sheets for further analysis. All successive calculations were also done
in Matlab.
For reﬂection mode measurements, the proximal pacing lead connector
pins were connected by miniature alligator clips to a short 75-ohm RG-59
coaxial cable and, through a 75-ohm N-type connector, to the test port of
the 35676B reﬂection kit. Before taking measurements, I performed one port
full calibration procedure of the connecting system at the frequency range
of interest with open, short and 75 ohm reference load. In order to calcu-
late the characteristic impedance Z0 of the pacing lead, open and short-end
impedances (Zopen and Zshort) were calculated from the respective reﬂection
coeﬃcient Γ measured directly with the 35676B kit:
Γopen/short =
Vreflected
Vincident
=
Zopen/short − Z0,line
Zopen/short + Z0,line
(4.8)
where Vreflected and Vincident are reﬂected and incident voltage in respect to
the device under test (DUT) which in this case corresponds to the pacing lead
[37], [42], [43]. Z0,line is the characteristic impedance of the test connection
system that was already calibrated to 75 ohm. The pacing lead characteristic
impedance Z0 was calculated using equation 4.6.
In order to obtain the values of the attenuation coeﬃcient for the leads,
I had to perform the transmission mode measurements. This procedure re-
quires two ports instead of only one in the previous case of reﬂection measure-
ment setup. The proximal lead connectors were connected in the same way
as for the reﬂection coeﬃcient measurement. The distal electrodes were con-
nected by alligator clips to a short 50-ohm RG-58 coaxial cable and, through
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Figure 4.1: Straight and J-shaped pacing lead - photo courtesy of Medtronic
a 50-ohm N-type connector, to the receiver port B of the network analyzer.
The calibration of the system is much simpler in this case, as it can be done
by shorting the respective input and output alligator clips. I measured the
linear ratio gain or transmission coeﬃcient deﬁned as
T =
Vtransmitted
Vincident
= e−γ·d = e−(α+jβ)·d (4.9)
where Vtransmitted and Vincident are transmitted and incident voltages in respect
to the pacing lead of length d and γ is the propagation constant [37], [42], [43].
The attenuation coeﬃcient α (Np/m) was easily calculated from equation 4.9:
α =
1
d
· ln 1
τ
(4.10)
where τ is the module of the transmission coeﬃcient T.
All above measurements have been carried out on 7 leads kept in saline
solution for more than a decade. The same measurements have also been
done for 13 new pacing leads and 2 high-voltage deﬁbrillator leads (mod-
els 6944 and 6947) produced by Medtronic (USA) and shown in Table 4.2.
These leads have never been soaked into the saline solution and I examined
the inﬂuence of lead shape (Fig. 4.1), conductor geometry (Fig. 4.2), and
insulation material on high-frequency parameters of these leads.
4.3.2 Results
Considering the old leads kept in saline, the Figures 4.3 and 4.4 show that the
penetration of the saline within the leads through the period of a decade did
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Figure 4.2: Diﬀerent types of lead design: Coaxial, parallel and co-radial conduc-
tors (from left to right) - photo courtesy of Medtronic
Lead Lead Name Shape Type Outer Insulation Inner Insulation
3830 SelectSecure Straight Coaxial Polyurethane(55D) Silicone(4719)/ETFE
4092 CapSure SP Novus Straight Coaxial Polyurethane(55D) Silicone(4719)
4194 Attain OTW Canted Coaxial Polyurethane(55D) Silicone
4196 Attain Ability Canted Co-radial Polyurethane(55D) Silicone polyimide
4396 Attain Ability Straight Straight Co-radial Polyurethane(55D) Silicone polyimide
4574 CapSure Sense J-shaped Coaxial Polyurethane(55D) Silicone(4719)
4592 CapSure SP Novus J-shaped Coaxial Polyurethane(55D) Silicone(4719)
5038 CapSure VDD2 Straight Parallel Silicone(MDX) /
5054 CapSure Z Novus Straight Coaxial Silicone(4719) Silicone(4719)
5076 CapSureFix Novus Straight Coaxial Silicone(4719) Silicone(4719)
5092 CapSure SP Novus Straight Coaxial Silicone(4719) Silicone(4719)
5568 CapSureFix J-shaped Coaxial Silicone(MDX) Silicone(MDX)
5592 CapSure SP Novus J-shaped Coaxial Silicone(4719) Silicone(4719)
6944 Sprint Quattro Straight Parallel Polyurethane(55D,80A) Silicone(4755)
6947 Sprint Quattro Secure Straight Parallel Polyurethane(55D,80A) Silicone(4755)
Table 4.2: New pacing and deﬁbrillation leads (ETFE - Ethylene tetraﬂuoroethy-
lene, Silicone MDX - Medical grade silicone, Silicone 4719 and 4755 - High perfor-
mance silicone elastomer)
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not inﬂuence much the HF characteristics of the leads, mainly the attenuation
coeﬃcient. This is a very important ﬁnding because of the primary intention
to use the HF lead measurements in chronically implanted leads. In fact, if
used as a lead bending sensor, penetration of the body ﬂuid will not aﬀect
its performance. If used in congestive heart failure monitoring, whereby long-
term deterioration of cardiac muscle forces will be measured, the modulation
of HF parameters by ﬂuid penetration may be taken into account. For that
purpose, a chronic study has to be done for speciﬁc lead conductor in order to
determine timely change of the HF lead parameters. If used as a connecting
cable of an ultrasonic sensor, there will be no signiﬁcant increase of the
battery drain in the implanted device due to the increased line losses.
Figure 4.3: Comparison of characteristic impedance values at 5, 10 and 20 MHz
for dry old leads (10 years ago) and after being kept in saline for a decade.
Fifteen new leads showed similar values of characteristic impedance and
attenuation compared to the old leads. The curves of the characteristic
impedance Z0 in the frequency range from 1 to 21 MHz shown in Figure
4.5 follow the typical theoretical rule of asymptotical approach towards a
ﬁxed value at higher frequencies. All asymptotic values are in the range from
70 Ω for the coaxial 4574 lead to 240 Ω for the parallel line of the 6944
deﬁbrillation lead formed by one of the low-voltage pacing conductors and
the longer high-voltage conductor positioned in the right ventricle. The mea-
surements showed that, in general, the parallel leads have higher values of Z0
compared to the coaxial leads. These experimental data agree with theoret-
ical results that in general conﬁrm higher values of characteristic impedance
54
4.3. LATEST ACUTE AND CHRONIC EXPERIMENTS
Figure 4.4: Comparison of attenuation coeﬃcient values at 10 and 21 MHz for
dry old leads (10 years ago) and after being kept in saline for a decade.
for twin lead conductors compared to coaxial cables for the same dielectric
material used. A good approximation for the characteristic impedance of a
coaxial cable with an inner radius a and outer radius b is
Z0,coaxial =
√
L
C
≈ 1
2pi
· µ
′
· ln( b
a
) (4.11)
where L and C are, respectively, inductance and capacitance per unit length,
µ is permeability and ′ is the real part of complex permittivity of the dielec-
tric between the conducting wires [37], [44]. A similar approximation can be
used for a characteristic impedance in the case of parallel wires:
Z0,coaxial =
√
L
C
≈ 1
pi
· µ
′
· ln(d
a
) (4.12)
where a is the radius of the conducting wire and d is the distance between
the centers of two conductors [37], [44]. A larger value for Z0,parallel compared
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Figure 4.5: Comparison of characteristic impedance values between 1 and 21 MHz
for all new leads. Shadowed zone comprises the curves for all remaining pacing
leads not shown separately. The measurements of diﬀerent combinations of parallel
conductors in deﬁbrillation leads are shown in an average value curve with standard
deviation superimposed.
to Z0,coaxial derives not only from the divisor 2 present in equation 4.11, but
also from the fact that normally the distance d has larger values compared
to the outer radius b of a coaxial cable.
Comparing coaxial pacing leads only, I observed larger values of Z0 for
3830 lead in the whole frequency range. It is a very thin 4.1 French (1.4
mm) lumenless lead with a diﬀerent inner insulation from other leads. It is
made of high-performance 4719 silicone [45] and ethylene tetraﬂuoroethylene
(ETFE). ETFE is the material with a very low relative dielectric constant
[44] making it a good insulation material with low capacitance per unit length
of the cable and, as a consequence, with high characteristic impedance.
I noticed a diﬀerent behavior for 4196 and 4396 Attain Ability left-
ventricular pacing leads. There is a saddle-like curve starting around 13 MHz.
This could be due to a diﬀerent type of inner insulator (silicone polyimide)
and a special co-radial design that allows to have a very thin bipolar lead (4
French lead body).
The most instructive comparison concerns diﬀerent types of coaxial Cap-
Sure SP Novus leads (4092, 4592, 5092, and 5592) shown in Figure 4.6. All
these leads have the same inner silicone 4719 insulation but diﬀerent outer
insulation (silicone 4719 for 5092 and 5592; polyurethane 55D for 4092 and
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Figure 4.6: The curve of characteristic impedance for straight leads (4092 and
5092) is almost identical in the whole frequency range. Very similar results are
obtained for J-shaped leads (4592 and 5592). The shape of the cardiac lead plays
a primary role in HF parameters.
4592). The curves clearly show that the characteristic impedance of straight
leads 4092 and 5092 is almost identical for the whole frequency range. The
same can be observed for J-shaped 4592 and 5592 leads. The measurements
reveal that in this case the only factor aﬀecting the characteristic impedance
is the lead geometry. This ﬁnding is very valuable for my future experiments
as it helps to explain the correlation of the instantaneous impedance vari-
ations to the lead bending during a heart muscle contraction. In fact, dur-
ing the myocardial contractions the lead geometry is continuously changing
which is directly related to the variation of the lead impedance and reﬂection
coeﬃcient making the lead itself a reliable heart contraction sensor.
As expected, the attenuation coeﬃcient α of all new leads increases with
the frequency as shown in Figure 4.7. It is kept under 0.9 Np/m for all coax-
ial and parallel leads. Co-radial leads 4196 and 4396 have somewhat higher
attenuation and a diﬀerent curve shape. Similarly to the case of characteris-
tic impedance, the attenuation coeﬃcient for the straight CapSure SP Novus
leads (4092 and 5092) is practically the same for all frequencies and somewhat
higher than α of the J-shaped CapSure SP Novus leads (Figure 4.8).
The acute measurements of the latest models of the leads revealed that
there is no signiﬁcant diﬀerence in attenuation coeﬃcient in comparison with
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Figure 4.7: Attenuation coeﬃcient values between 1 and 21 MHz for all new
leads. Shadowed zone comprises the curves for all remaining pacing leads not shown
separately. The measurements of diﬀerent combinations of parallel conductors in
deﬁbrillation leads are shown in an average value curve with standard deviation
superimposed. Co-radial leads 4196 and 4396 have a completely diﬀerent curve
compared to parallel and coaxial leads.
the old lead models. This is expected because geometry and materials used
in lead design did not change dramatically during the decade. Coaxial lead
conductor remained the standard of the bipolar lead design for many years.
An exception are the newly designed co-radial lead conductors that exhibited
a greater increase of the attenuation coeﬃcient at higher frequencies.
4.4 Conclusions and Applications
The chronic results of my research on HF characteristics showed the long-
term stability of impedances and attenuation coeﬃcients for most diﬀerent
types of the leads independently on materials used for insulation or geometry
design of the cardiac lead.
The acute results for new leads showed that HF characteristics have mu-
tually very similar values. Therefore, they would perform in a similar way if
used as hemodynamic sensors. Accordingly, a universal HF measurement cir-
cuit within an implantable device could be designed in order to be used with
every cardiac lead. In order to increase the measurement accuracy, circuit
calibration procedure should be developed.
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Figure 4.8: Attenuation coeﬃcient values between 1 and 21 MHz for Capsure
SP Novus leads. The straight leads 4092 and 5092 are presenting almost identical
values of attenuation coeﬃcient in the whole frequency range. J-shaped leads have
a very similar behavior, although not completely identical.
If the HF characteristics were studied for every cardiac lead used in clin-
ical practice, the circuit calibration could be adapted to the speciﬁc lead's
characteristic impedance by simple programming of the lead model which
is normally done today in the most of the devices but only for the purpose
of clinical information. Further chronic analyzes would be useful in order to
conﬁrm the long-term stability of HF parameters as already announced by
the results obtained with 7 old leads kept in saline for a decade. For that pur-
pose, I soaked ﬁfteen new leads in the physiologic solution and I will revalue
their HF parameters after a longer period of steeping.
There could be three diﬀerent goals in HF cardiac lead design: increasing
the sensitivity of the lead bending sensor, decreasing the sensor's cable losses
in the case of the intra-cardiac HF sensor application such as ultrasonic and
decreasing the sensitivity on MRI electromagnetic ﬁeld [46]. I may conclude
that primarily the lead conductor design geometry and than the choice of the
insulation material may achieve any of the goals and the speciﬁc application.
The HF impedance matching on the sending end but also at the receiving
end of a lead conductor should be investigated in speciﬁc applications [47].
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Chapter 5
High Frequency Sensor
5.1 Introduction
As described in the previous Chapter, it would be a major advantage for
an implantable device to comprise a hemodynamic sensor being functional
with every standard cardiac lead independently of the lead manufacturer.
This would enable a simple upgrade of the therapy system at the device
replacement procedure.
The main purpose of such hemodynamic sensor would be to monitor the
mechanical activity of the heart in order to enable highly accurate auto-
matic functions such as threshold measurement and rate responsive pacing
[48]. Especially in implantable cardioverters deﬁbrillators, the sensor could
yield diﬀerentiation between hemodynamically stable and unstable tachycar-
dia thereby tailoring the therapy accordingly [28].
The previous Chapter describes in detail the HF characteristics of dif-
ferent kinds of bipolar leads. The geometry of the lead was found to be the
essential parameter inﬂuencing those characteristics. In vitro experiments,
that I carried out later on, have conﬁrmed that the HF impedance of any
bipolar lead varies dynamically in correspondence to the ﬂexion of the lead
and it is easily measurable. In the same way, it is possible to detect car-
diac contractions and successive lead bending by measuring either the HF
impedance or any other HF parameter directly related to the impedance. In
order to investigate a possibility of constructing a hemodynamic sensor based
upon HF parameters, I have conducted a series of animal and human experi-
ments. Instead of measuring directly the impedance, I have mainly measured
the reﬂection coeﬃcient at diﬀerent signal frequencies ranging from 1 to 200
MHz. In fact, the Equation 4.8 shows that these two parameters are directly
related to each other and are interdependent. I chose the reﬂection coeﬃ-
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cient only for practical reasons and because of the available measurement
instrumentation.
5.2 Measurement Setup
The reﬂection coeﬃcient measurement was carried out using the network an-
alyzer (3577B, Hewlett-Packard - HP, USA) and the transmission/reﬂection
test kit (35676B, HP, USA). For that purpose, I built a dozen of 75-ohm
coaxial patient cables having alligator clips for lead connection on one side
and a standard F connector on the other side. These cables were sterilized for
usage in the sterile ﬁeld. A short non-sterile coaxial cable was connecting the
patient cable to the 75-ohm N-connector at the test port of 35676B. The ac-
quisition of the measured values to the mobile workstation (Precision M6400,
Dell, USA) via the standard GPIB interface and the corresponding Express
Card (National Instruments - NI, USA) was commanded by a Matlab script
(MathWorks, USA).
Other signals during ovine experiments were acquired through the Na-
tional Instruments connector block and further through the acquisition PCM-
CIA card (DAQCard-6024E, National Instruments, USA) inserted in Pre-
cision M6400 mobile workstation. Namely, the ECG, VEGM and AEGM
signals were acquired via the 2290 analyzer block of the 2090 CareLink
programmer (Medtronic, USA) and the analog input/output box (2090AB,
Medtronic, USA). The process of waveform acquisition via DAQCard-6024E
was programmed using LabView 2009 SP1 (National Instruments, USA) soft-
ware and the numerical data were saved into Excel sheets (Microsoft Oﬃce,
Microsoft, USA) for further processing and graphic presentation. Complete
system is disclosed in Figure 5.1. Using the frame grabber hardware (CMP-
USBVG4, König computer, Netherlands), I recorded the ﬂuoroscopy brought
to the grabber in form of composite signal directly from the screen output.
In human experiments, the setup was pretty much the same except that I
was able to acquire the ECG signal from the signal input/output box of the
RECOR monitoring system (Siemens-Elema, Sweden). The ﬂuoroscopy was
recorded independently in DICOM format using the system already present
in the catheterization laboratory.
Before taking measurements, I performed one port full calibration proce-
dure of the connecting system with open, short and 75 ohm reference load,
as disclosed in Figure 5.2. I did the majority of the measurements utilizing
the signal frequency of 10 and 50 MHz. However, pilot measurements have
been also done at 1, 20, 100 and 200 MHz.
62
5.2. MEASUREMENT SETUP
Figure 5.1: High frequency sensor - measurement setup
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Figure 5.2: Sterile black coaxial RG59 cable is terminated by alligator clips. Grey
cable is connected to the pacemaker signal analyzer (PSA) for standard threshold-
sensing testing. The surgeon ﬁxes the 75 ohm resistor to the alligator clips for the
third phase of the measurement system calibration.
5.3 Acute Animal Experiments
5.3.1 Methods and Materials
The acute animal experiments have been performed at the Faculty of Vet-
erinary Medicine in Zagreb, Croatia. The measurement system was tested
simultaneously to the experiments done with the triboelectric sensor during
the implants of the same leads in the same 8 sheep. The only diﬀerence con-
sisted in one more sheep used for HF experiments in which we implanted the
custom-made 2-dot electrodes lead. This type of the lead was already used
in two other sheep and is described in Section 3.3.
Similar to the triboelectric sensor, the HF sensor was tested at baseline
and during acute hemodynamic interventions (dobutamine infusion) in order
to achieve a heart rate of minimum 160 beats/minute and not to exceed 220
beats/minute. Other details concerning the implants are disclosed in detail
in Section 3.3 describing the experiments with the triboelectric sensor.
Any combination of parallel or coaxial conductors can be seen as a trans-
mission line. Accordingly, I used diﬀerent pairs of conductors for the mea-
surement of the reﬂection coeﬃcient. In 5 custom-made ICD leads, I tested
the classic low-voltage bipolar conﬁguration between the pace/sense conduc-
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tors. I was also able to measure the signal between diﬀerent combinations
of low-voltage and both high-voltage conductors, including the high-voltage
conductor with the dead-end isolated conductor. In the 6-ring electrode lead
I could measure the reﬂection coeﬃcient between the pace/sense conductor
and one of the six conductors of the ring electrodes as well as between dif-
ferent pairs of ring electrodes. The 2-dot lead has a dedicated conductor for
each of the dots and a dead-end conductor inserted within the whole length
of the lead body. In this case, I also examined each couple of conductors.
In addition, in the ICD leads and the 6-ring lead I measured the unipolar
conﬁguration between the pace/sense conductor and the skin. Valid measure-
ments were also obtained when measuring the signal between the pace/sense
lead and the nylon-coated wire inserted in stylet channel forming another
type of coaxial transmission line with nylon coating as insulation between
two conductors.
5.3.2 Results
I was able to record the HF reﬂection signal variation, caused by the ven-
tricular lead bending, in all nine sheep. The quality of the HF signal varies
in diﬀerent pairs of conductors and for diﬀerent signal frequencies but in the
majority of cases the reﬂection coeﬃcient waveform obtained by the mea-
surement system corresponds to the cyclic occurrence of QRS complexes and
T waves on the ECG waveform. The Figure 5.3 shows the waveform obtained
from the transmission line formed by two parallel pace/sense conductors in
one of the ICD leads at 10 MHz. The heart was beating in sinus rhythm at
95 bpm. The following example was obtained in the same lead during the
dobutamine test at 188 bpm (Figure 5.4). In both cases there is an obvious
correlation between the ECG and EGM traces and the reﬂection coeﬃcient
waveform that describes the lead bending and the myocardial contraction.
Further analysis of the reﬂection coeﬃcient waveform in case of sinus
rhythm is given in Figure 5.5. The positive slope starts at the end of the QRS
complex and corresponds to the myocardial contraction during the systolic
phase of the cardiac cycle. A small inﬂection occurs on the waveform shortly
after the beginning of the contraction. It deﬁnes the end of the isovolumic
contraction and the beginning of blood ejection into the pulmonary artery. In
fact, the ejection starts when the pulmonary valve opens after the pressure
in the right ventricle rises above the pressure in the pulmonary artery. An
extremely fast blood movement drags one segment of the lead body towards
the pulmonary valve at the base of the right ventricle which is very close
to the tricuspid valve where the lead enters the ventricle. At the end of
ventricular systole, when the pressure in the right ventricle falls rapidly, the
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Figure 5.3: Reﬂection coeﬃcient signal (|Γ|) measured in the ICD lead between
the pace/sense conductors at 10 MHz during sinus rhythm (95 bpm). The middle
waveform is the ventricular unipolar EGM.
Figure 5.4: Reﬂection coeﬃcient signal (|Γ|) measured in the ICD lead between
the pace/sense conductors at 10 MHz during dobutamine test (188 bpm). The
middle waveform is the ventricular unipolar EGM.
pressure in the pulmonary artery closes the pulmonary valve. A small artifact
in the HF signal waveform at the end of ventricular systole marks the closure
of the pulmonary valve. This event contributes to the second heart sound in
cardiac auscultation.
The initial phase of the diastole, i.e. isovolumic relaxation, is represented
by a slightly negative slope segment in the HF signal waveform. It is followed
by a steep negative slope due the rapid blood inﬂow after the opening of
the tricuspid valve. The second almost horizontal segment represents the
66
5.3. ACUTE ANIMAL EXPERIMENTS
Figure 5.5: Reﬂection coeﬃcient signal (|Γ|) measured in the ICD lead between
the pace/sense conductors at 10 MHz during sinus rhythm (95 bpm). The middle
waveform is the ventricular unipolar EGM. Diﬀerent phases of the cardiac cycle
are shown.
phase of diastasis. It is the middle stage of diastole where the initial passive
ﬁlling of the right ventricle has slowed down. It is followed by the atrial
contraction and the second phase of ventricular ﬁlling known as A wave in
echocardiography. In the HF signal waveform it is visible as the second steep
negative slope. A small inﬂection of the waveform, positioned just before the
end of the diastole, represents the closure of tricuspid valve and the end of
ventricular ﬁlling.
An analogous graphic segmentation of the waveform obtained during
dobutamine test is given in Figure 5.6. In this case, the valve movements
are less visible. This may happen for two reasons. First, the cardiac con-
tractions are much more vigorous during dobutamine test and these short
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changes of the blood ﬂow direction might not inﬂuence that much the lead
bending. Another reason might be the limited number of visualization points
of the HF signal. In fact, I am able to fetch from the network analyzer only
one screen per measurement and each screen gives maximum 401 points. Ob-
viously, for faster cardiac rhythms I lose some information if I keep the same
recording interval which is 8 seconds in this case. Nevertheless, I was still able
to determine diﬀerent phases of systole and diastole by using the steepness
of the slopes as guidance. I was not able to ﬁnd any correlation between the
Figure 5.6: Reﬂection coeﬃcient signal (|Γ|) measured in the ICD lead between
the pace/sense conductors at 10 MHz during dobutamine test (188 bpm). The
middle waveform is the ventricular unipolar EGM. Diﬀerent phases of the cardiac
cycle are shown.
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peak-to-peak amplitude of the reﬂection coeﬃcient variation and the con-
tractility. In most of the cases this amplitude was found to be even smaller
during the dobutamine test. The most probable reason is that stronger and
faster contractions do not allow the lead to complete its movement as it is
the case during sinus rhythm. Consequently, the HF impedance and the re-
ﬂection coeﬃcient do not change in the same amount as in the case of sinus
rhythm.
Figure 5.7: Reﬂection coeﬃcient signal (|Γ|) measured in the ICD lead between
the pace/sense conductors at 10 MHz during sinus rhythm (95 bpm). The arrows
are pointing to the start of the systole (waveform minima) and to its end points
(waveform maxima) with respective values
Figure 5.8: Reﬂection coeﬃcient signal (|Γ|) measured in the ICD lead between
the pace/sense conductors at 10 MHz during dobutamine test (188 bpm). The
arrows are pointing to the start of the systole (waveform minima) and to its end
points (waveform maxima) with respective values
Later on, I analyzed the duration of the contraction relatively to the heart
cycle interval in sinus rhythm and during the stress test. Figures 5.7 and 5.8
show the same waveforms previously analyzed and segmented in diﬀerent
cardiac cycle phases. The arrows are indicating starting and ending points of
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systole in both normal and accelerated rhythms with relative timing points
and values of reﬂection coeﬃcient module. The following calculations give
as a result the relative duration of the contraction period compared to the
complete heart cycle duration in sinus rhythm Tcontraction,rel,SR:
Tcontraction,rel,SR =
Tcontraction,SR
Tcycle,SR
=
t2 − t1
t3 − t1 =
0.2
0.64
= 0.3125 (5.1)
Exactly the same relative duration is obtained in the case of the dobutamine
test and it amounts to around one third of the heart cycle:
Tcontraction,rel,DOB =
Tcontraction,DOB
Tcycle,DOB
=
t2 − t1
t3 − t1 =
0.1
0.32
= 0.3125 (5.2)
I also noticed a strong correlation between the slew rate of the HF signal
and the myocardial contractility. I calculated the derivation of the positive
slope of the HF signal that represents the contraction phase. For the ﬁrst
heart cycle during the sinus rhythm it amounts to
∆|Γ|
∆Tcontraction,SR
=
|Γ2| − |Γ1|
t2 − t1 =
0.407− 0.351
0.2
= 0.28 (5.3)
In the second cycle, the derivation is
∆|Γ|
∆Tcontraction,SR
=
|Γ4| − |Γ3|
t4 − t3 =
0.405− 0.355
0.22
= 0.23 (5.4)
The diﬀerence between two values can be attributed to a relatively low time
resolution of the acquired signal as I was able to acquire only 401 points for
each measurement with the network analyzer. For a longer acquisition of 8
seconds, the measurements are taken every 0.02 seconds. This is a source of
considerable errors around the signal peaks.
The same calculations were done for the waveform during the stress test.
The slew rates are respectively 0.59 and 0.58 in the ﬁrst two heart cycles.
The HF signal rises twice as rapidly during the dobutamine test. This gives
an indication of a strong correlation between the sensor signal increase rate
and the myocardial contractility.
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This observation was conﬁrmed with the further analysis of the rest of
acquired waveforms although a strictly mathematical approach was not un-
dertaken. In fact, the acquisition system shortcoming in terms of low tem-
poral resolution resulting in unreliable signal peek values have impeded the
building of a solid statistical model. This limitation does not diminish the
value of the results of the experiments. Conversely, it gives a precise indica-
tion for the future experiments and an announcement of an extremely simple
and steady method for myocardial contractility evaluation.
5.4 Acute Human Experiments
5.4.1 Methods and Materials
The acute human experiments have been performed using the standard pac-
ing and deﬁbrillator leads during regular primary implantations or replace-
ments of pacemakers and ICDs under local anesthesia.
The measurement system was tested in 28 patients with indications for
pacemaker or ICD implantation in accordance with standard international
guidance. Twelve patients have undergone ICD implantation (7 dual chamber
and 5 single chamber). A pacemaker was implanted or replaced in the other
sixteen patients with 11 dual chamber and 5 single chamber devices. The
ventricular leads were positioned in the right ventricular apex and the atrial
leads in the right atrial appendage. Both sites are standard pacemaker lead
positions.
5.4.2 Results
I was able to record the HF reﬂection signal modulation caused by the lead
bending in 24 patients. The wave obtained by HF measurements system oc-
curred always after the QRS complex during expected ventricular contraction
period whereby timely corresponding to the oxygen saturation (SO2) wave. In
dual chamber system, the HF measurement was not possible in 4 patients due
to the rhythmic intra-atrial collision of two lead bodies that generated the
huge signal artifact. We were able to observe the sensor response in diﬀerent
underlying rhythms - atrial ﬁbrillation with bradyarrhythmia, atrioventricu-
lar blocks of diﬀerent grades, and sinus bradycardia.
The measurements prolonged the normal testing procedure for maximum
10 minutes. Deﬂection of the ventricular lead occurred in its distal portion
at the curvature within the tricuspid valve. Cardiac contractions pulled the
right ventricular segment of the lead in cranial direction thereby ﬂexing the
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tricuspid and low atrial segments of the lead. Diﬀerent positions of the lead
tip implantation yielded diﬀerent lead deﬂection and diﬀerent signal magni-
tude. Periodic variation of the cardiac contraction signal corresponds to the
periodic variation of the bending curve of the lead within the right ventricle.
Figure 5.9 shows measured signals of the patient with arrhythmogenic RV
dysplasia and sustained VT, recorded during implantation of a dual cham-
ber ICD. Two Medtronic leads: ventricular 6944-65 and atrial 5554-53 were
implanted in RV apex and RA appendage respectively. The measurements of
the high frequency reﬂection coeﬃcient magnitude (|Γ|) have been done by a
bipolar connection to the coaxial atrial lead at the frequency of 20 MHz. Sen-
sor signal of atrial lead is on the top above unipolar atrial EGM and surface
ECG. A premature ventricular contraction (PVC) inﬂuences the atrial lead
bending and therefore the PVC signal is visible as a signal having decreased
amplitude in comparison with other normal sinus rhythm complexes.
Figure 5.9: Reﬂection coeﬃcient signal (|Γ|) measured in the atrial bipolar lead at
20 MHz. The middle waveform is atrial unipolar EGM. PVC inﬂuences the atrial
lead bending.
Figure 5.10 shows measured signals of the patient with dilative cardiomy-
opathy and non-sustained VT, recorded during the implantation of a dual
chamber ICD with the same two leads as in the previous case. The mea-
surements have been done at the frequency of 10 MHz between the proximal
SVC (superior vena cava) high-voltage conductor and the RV ring connector
of the deﬁbrillation lead. This is an example of a parallel transmission line.
Atrial pacing at the rate of 130 ppm provoked 2:1 AV block. Small atrial con-
traction wave precedes the tall ventricular contraction wave and the other
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non-conducted atrial contraction is superimposed on the ventricular wave.
Figure 5.10: Reﬂection coeﬃcient signal (|Γ|) measured in the deﬁbrillation lead
between SVC and RV ring connector pins at 10 MHz. Atrial pacing at 130 ppm
provoked 2:1 AV block.
Figure 5.11: Reﬂection coeﬃcient signal (|Γ|) measured in the deﬁbrillation lead
between HVB and RV ring connector pins at 10 MHz. The middle waveform is
ventricular unipolar EGM. HF sensor signal amplitude variation in related to R-R
interval variation.
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Figure 5.12: Reﬂection coeﬃcient signal (|Γ|) measured in the deﬁbrillation lead
between HVB and RV ring connector pins at 10 MHz. The middle waveform is
ventricular unipolar EGM. Intermittent loss of capture occurs during RV pacing
at 90 ppm.
A patient in atrial ﬁbrillation with dilative cardiomyopathy (DCM) is il-
lustrated in Figure 5.11. The HF signal was recorded during a single chamber
ICD implantation on Medtronic 6944-65 ICD lead between the distal HVB
high-voltage conductor and the RV ring conductor utilizing the frequency of
10MHz. Diﬀerent HF sensor signal amplitude is obtained after diﬀerent R-R
intervals.
Figure 5.12 illustrates the signal recorded in the same manner in the
previous patient. In this case, an intermittent loss of capture occurs during
RV pacing at the rate of 90 ppm. Diﬀerent contraction patterns for paced
and native QRS complexes are clearly visible in the HF signal waveform.
5.5 Conclusions and Possible Extensions
The experiments proved that every standard lead is a myocardial contrac-
tion sensor that functions acutely in sheep and humans without any special
hardware mounted on the lead body. The HF sensor is also operating appro-
priately in chronically implanted leads in humans. I have demonstrated its
good performance with diﬀerent types of atrial and right ventricular leads.
The experiments in human patients have not shown any marked diﬀerence
in signal quality relative to diﬀerent underlying pathologies although this
should be further investigated with a larger patient pool.
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The main disadvantage of the method is of purely practical nature. In
fact, the network analyzer allows the acquisition of one screen per measure-
ment. One screen has 401 points and for a measurement of 8 seconds it gives a
temporal resolution of 20 ms. This is not good enough for the representation
of the signal with a high slew rate. In my case, some of the signal peaks were
not registered with adequate precision which makes impossible any further
statistical analysis of the signal. I am currently developing some additional
hardware to overcome this problem: a signal generator and an HF bridge op-
erating at the frequency between 10 and 50 MHz. The imbalance of the bridge
due to the cardiac contractions will provide me with a continuous signal. In
order to mathematically formalize the results, this signal will be correlated
to the ﬂuoroscopy movie and hemodynamic parameters such as rate of rise
of LV pressure (dp/dt) and saturation of peripheral oxygen (SpO2). Further
investigation will include chronic measurements in same nine sheep. Later
on, I will expand the measurements to other human patients for whom we
are currently waiting an additional approval of the ethical committee as an
invasive procedure of catheterization is required for dp/dt curve acquisition.
I will also further investigate the ﬁdelity of atrial and RV leads signal,
especially in the case of intra-atrial collision of two lead bodies that gen-
erated the signal artifact in previous experiments. Further improvement of
the hardware and software should solve the problem. I need to determine
the feasibility of recording HF reﬂection signal caused by LV lead bending
in the coronary sinus as this might give an indication of LV contraction. It
would give very valuable information potentially exploitable for automatic
CRT optimization - the major challenge of modern electrotherapy systems
which is not yet solved. In addition, I will need to analyze the inﬂuence of
the signal frequency on the ﬁnal quality of the waveform. First observations
have shown satisfactory results at 10-50 MHz although in some cases I had
to use higher frequencies to obtain clear contraction waves.
There is a great potential to investigate the variety of possible clinical
utilities of this sensor already introduced in Section 2.2.2. I assume that
existing studies for commercially available contractility sensors could be re-
peated with our system. Furthermore, the major advantage of our system in
comparison to the existing systems is that every standard bipolar cardiac lead
may be the cardiac contraction sensor without any special device mounted
on its body. Additional HF hardware in cardiac devices would be neither de-
sign challenge nor source of decreased battery longevity. It would not impose
additional safety or reliability risk. Although the results obtained with HF
sensor are extremely promising, additional clinical studies have to be done in
the future in order to investigate thoroughly the clinical applications before
being able to integrate the system in the implantable devices.
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Chapter 6
Conclusion and Future Work
6.1 Summary and Contributions
In this thesis, I have explored the possibility of building a hemodynamic sen-
sor for myocardial contraction detection that could be easily integrated in the
existing cardiac pacing and deﬁbrillator leads. Therapy delivery in modern
cardiac electrotherapy systems is based almost exclusively on the informa-
tion about cardiac electrical depolarization. This kind of detection lacks any
information about the mechanical component of myocardial contraction that
is considered even more useful for the ﬁnal scope of heart pump function
evaluation.
A short introduction to the problem and the organization of the report
are given in Chapter 1.
A vast research of literature has been carried out in Chapter 2. Cur-
rently, there are only three cardiac pacing systems in the market that suc-
cessfully gather information on cardiac contractions. However, one of them
requires a special lead with an accelerometer in the lead tip while the other
two are based on impedance measurements and have very limited practical
application. The aim of my research was to ﬁll this gap in the pacing therapy
and propose a new solution that will be simple and universal for all kind of
leads. This sensor would preferably have a wider range of applications and
would markedly improve the patient management.
In Chapter 3, I have disclosed in detail the design and applications of a
hemodynamic sensor based on triboelectricity that was the fruit of collabo-
ration with my co-tutor Ferek-Petric. The system detects the built of charge
within the cardiac pacing lead due to the lead bending and consequent fric-
tion of conductive and insulation materials that build up the lead itself. Even
better signal quality was obtained when measuring the charge between one
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of the pacing conductors and a special insulated metallic wire used as stylet
in the central lumen of the lead. The system was thoroughly tested in a series
if animal and human experiments.
In Chapter 4, I have presented an original study on electrical high-
frequency parameters of cardiac leads. Ferek-Petric has previously conducted
a series of measurements of characteristic impedance and attenuation coef-
ﬁcient on six dry pacing leads. I have repeated the measurements after the
ten-year period of soaking the leads in physiologic solution for human body
environment simulation. The results have shown a surprising stability of HF
parameters independently of the extremely long time spent in NaCl solution.
I have also analyzed the same parameters in 15 new pacing and ICD leads
and immersed them in saline for future experiments. Almost all new leads
have shown similar values of impedance and attenuation to those pertinent
to old leads. The only exception were two modern co-radial LV leads with a
completely new design. The main ﬁnding of the experiment was the extreme
sensibility of HF parameters to the lead geometry variation.
That was an important and encouraging result for the upcoming develop-
ment of the HF lead bending sensor presented in Chapter 5. In fact, we have
considered any bipolar cardiac lead to be a transmission line. Intraoperative
measurements of HF reﬂection coeﬃcient in sheep and humans have clearly
demonstrated the feasibility of such sensor. In fact, the lead ﬂection due to
the cardiac contractions changes the HF impedance of the lead and serves
as a consistent hemodynamic sensor. The main value of this novel technique
stands in its simplicity and possibility of its universal expanding to all ex-
isting bipolar leads. This achievement is unique in the ﬁeld of hemodynamic
sensors applied to the cardiac pacing.
The potential area of applications of two sensors presented in the the-
sis is huge. Beat-to-beat monitoring of electromechanical coupling intervals
could be used in capture management algorithms. Tachycardia detection al-
gorithms could be signiﬁcantly improved as hemodynamic unstable tachy-
cardia impedes the heart muscle contractility [28]. It may be also used as a
rate responsive sensor because the exercise signiﬁcantly changes the contrac-
tility [49], [50]. Considering that the heart failure inﬂuences the parameters
of RV and LV contractility [9], [21], [51], a continuous heart failure monitor-
ing might be obtained with these sensors. AV interval closed loop regulation
should be investigated by RV contraction optimization [52], [53] as well as VV
delay regulation in CRT hemodynamic optimization [54]. Atrial ﬁbrillation
detection, mode switching and post-AF therapy titration is also one of the
possible applications. In that regard, detection of hemodynamic assessment
of atrial ﬁbrillation [55], [56], and post-AF therapy eﬀects evaluation [57]
should be investigated. As vigorous contractions precede the vagal reaction
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[58], [59], the vasovagal syncope episode could probably be predicted by our
sensors.
The main contribution of this thesis can be found in its original interdis-
ciplinary approach to the problem of hemodynamic sensor design. In those
regards, the main signiﬁcance stands in simplicity and universality of the pro-
posed sensors, especially in the case of sensor based on HF lead parameters.
The quality of results is proven in numerous ovine and human experiments in
diﬀerent conditions and the originality of the studies is proven by the entire
patent portfolio held by my co-tutor Ferek-Petric.
6.2 Future work
There is still a long way to the practical use of the proposed sensors. In the
future experiments, I will correlate the sensor signal with ﬂuoroscopy movie
and hemodynamic parameters such as dp/dt and SpO2. I will also proceed
to the design of HF bridge that will provide continuous output signal instead
of the limited number of points acquired from the network analyzer in the
case of HF sensor. Further investigation will include chronic measurements in
same nine sheep. Later on, I will expand the measurements to other human
patients. The last step would be to integrate the measurement system into
the implantable device and have continuous monitoring and registration of
the sensor signal that could prove its long-term stability and possibility of
integrating the system in the commercially available devices.
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XXIICICLO 

II giomo 07 Dicembre 2010, aIle ore 11.30 pres so il Dipartimento di Ingegneria Industriale e 
dell'Informazione (DI3) si eriunito, regolarmente convocato, il Collegio dei Docenti del Dottorato 
di Ricerca in Ingegneria dell'Informazione. Fra i componenti del collegio dei docenti sono presenti 
Ie persone di seguito indicate: 
Presente Assente Assente 
giustificato non 
giustificato 
IA ;<1;J AgO:::;tlIlO X 
i Babich Fulvio X 

Albelio 
 X 
I 
! Carrato Sergio X I 
I X 	 I 
l Parisini Thomas 
MUlnolo Enzo 
X 
i Ramponi Giovanni X 
I Russo Fabrizio X 
! UkOVll.:h 'alter I 
X 	 IT:" 1~'1 :"IL,d 
e:::;l,.;ovo Roberto 
 X I 
Sono inoltre presenti il prof Lorenzo Castelli e la dr. Federica Vatta, tutrice del dottorando 
Meneghini. 
Presiede il prof Vescovo. Verbalizza il prof Ramponi. 
II presidente, constatato il nUlnero legale, apre 1a riunione alle ore 11.30 per trattare il seguente 
ordine del giomo: 
1. 	 Valutazione dell'attivita svolta dai dottorandi che hanno concluso i1 quarto anna in regime 
di proroga ed eventuale loro ammissione all'esame finale. 
2. 	 Redazione della tesi di dottorato in lingua inglese. 
3. 	 Scelta della cOlnmissione dell' esatne finale. 
4. 	 Varie ed eventuali. 
IL PRESIDENTE IL SEGRETARIO 
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Prima di iniziare Ie valutazioni, il coordinatore ricorda che restano iscritti al dottorato soltanto Ie 
seguenti persone: MENEGHINI Fabio, MORO Alessandro, TOMASIC Danko, i quali terminano il 
quarto anna in di proroga, concessa nell'anno 2009. 
1. Valutazione dell'attivita svolta dai dottorandi che hanno concluso il quarto anna in regime 
di proroga ed eventuale lora ammissione all'esame finale. 
1. 	 MENEGHINI Fabio (tutore dr. Federica VATTA) 
II dottorando presenta la propria attivita e risponde alle domande ed osservazioni da parte del 
Collegio. 
2. 	 MORO Alessandro (tutore prof, Enzo MUMOLO) 
II dottorando presenta la propria attivita e risponde alle domande ed osservazioni da parte del 
Collegio. 
3. 	 TOMASIC Danko (tutore prof. Agostino ACCARDO) 
II dottorando presenta la propria attivita e risponde alle domande ed osservazioni da parte del 
Collegio. 
II Collegio apprezza la proficua attivita svolta dai.dottorandi MENEGHINI Fabio, MORO 
Alessandro e TOMASIC Danko, che nel corso dell'ultimo anno, in regime di proroga, hanno 
mostrato di aver completato iliavoro svolto nei primi tre anni, e ne delibera l'ammissione all'esame 
finale. 
Delibera inoltre di sottoporre alIa commlSSlone dell' esame finale Ie presentazioni dei detti 
dottorandi cosi come preparate dai rispettivi tutori. Tali presentazioni sono allegate al presente 
verbale. 
2. Redazione della tesi di dottorato in lingua inglese 
I1 Collegio de1ibera di concedere la redazione della tesi in lingua inglese ai dottorandi che ne 
ravvisassero l' opportunita. 
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3. Scelta della commissione dell'esame finale 
Dopo approfondita discussione, il Collegio delibera di proporre, all'unanimita, che la commissione 
per l' esame finale del Dottorato sia la medesima dell' esame finale della scuola di Dottorato in 
Ingegneria dell'Informazione (XXIII cicIo), istituita presso il Dipartimento di Ingegneria Industriale 
e dell'Informazione dell'Universita di Trieste e diretta dal prof. Walter Ukovich, presente ana 
nunlOne odiema. II collegio propone inoltre che tale commissione sia.folmata dalle seguenti 
persone: 
1. 	 Prof. Alberto BARTOLI, Universita di Trieste, Dipartimento di Ingegneria Industriale e 
dell'Informazione, Via A. Valerio 10, 34127 TRIESTE. (Tel. 040-5587822, E-mail: 
bartoli.alberto@units.it, Fax: 040-5583460). 
2. 	 Prof. Michele MIDRIO, Universita di Udine, Dipaliimento di Ingegneria Elettrica, 
Gestionale e Meccanica, Via delle Scienze, 208, 33100 UDINE. (Tel. 0432-558292, E-mail: 
midrio@uniud.it, Fax: 0432-558251). 
3. 	 Prof. Alfredo RUGGERI, Universita degli studi di Padova, Dipartimento di Ingegneria 
dell'Informazione, Via Gradenigo 6/B, 35131 PADOVA (Tel. 049-8277624, E­
mail:alfredo.ruggeri@dei.unipd.it, Fax: 049-8277699). 
4. 	 Componente aggregato: Prof. Franco BLANCHINI, Universita di Udine, Dipartimento di 
Matematica e Informatica, Via delle Scienze, 208, 33100 lJDINE (Tel. 0432-558466, E­
mail: blanchini@uniud.it, Fax: 0432-558499). 
Vengono inoltre designati, all'unanimita, i seguenti merrlbri supplenti (commissione di riserva): 
1. 	 Prof. Enzo MUMOLO, Universita di Trieste, Dipartimento di Ingegneria Industriale e 
dell'Informazione, Via A. Valerio 10, 34127 TRIESTE (Tel. 040-5583861, E-mail: 
mumolo@univ.trieste.it , Fax: 040-5583460). 
2. 	 Prof. Giuseppe SCHETTINI, Universita di Roma Tre, Dipartimento di Elettronica 
Applicata, Via della Vasca Navale, 84, 00146 ROMA (Tel. 06-57337336, 
mail:schettin@uniroma3.it, Fax: 06-57337026). 
3. 	 Prof. Gianna TOFFOLO, Universita di Padova, Dipartimento di Ingegneria 
dell'Informazione, Via Gradenigo 61B, 35131 P AD OVA (Tel. 049-8277804, 
mail:toffolo@dei.unipd.it, Fax: 049-8277699). 
4. 	 Componente aggregato: Prof. Stefano MIANI, Universita di Udine, Dipartimento di 
Ingegneria Elettrica Gestionale e Meccanica, Via delle 208, 33100 UDINE (Tel. 
0432-558262, E-mail: miani.stefano@uniud.it, Fax: 0432-558251). 
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L'esame si terra locali del Dipartimento di Ingegneria Industriale e dell'Informazione (DI3) 

dell'Universita di Trieste .. 

Il collegio del ega il proprio coordinatore, prof. Vescovo, e il Direttore della scuola di Dottorato 

sopra citata, prof. Ukovich, a definire un'unica data per l'esame finale dei candidati del dottorato e 

della Scuola. Data e ora saranno poi da essi comunicate in tempo utile alIa segreteria dottorati. 

6.Varie ed eventuali 
Constatata l'assenza di varie ed eventuali, il Presidente dichiara chiusa la seduta aIle ore 12:30. 
ALLEGATI AI, A2, A3 al presente verbale: 
Presentazioni, alIa commissione dell' esame finale, dei candidati MENEGHINI Fabio (Allegato AI), 
MORO Alessandro (Allegato A2), TOMASIC Danko (Allegato A3). 
IL PRESIDENTE SEGRETARIO 
Allegato A3 (verbale n. 48 della riunione delCollegio dei Docenti del 07-12-2010) 
Dottorato di Ricerca in Ingegneria delI'Informazione 
Presentazione del dottorando Danko Tomasic 
alIa Commissione dell' Esame finale 
Danko Tonlasi6 ha iniziato il dottorato nel gennaio 2007, indirizzo Bioingegneria, senza borsa. Ha 
svolto la sua attivita a Hvello intemazionale, sia presso la Facolta di Ingegneria dell'Universita di 
Zagabria, sia presso i laboratori di ricerca della Medtronic, l'Universita di Leuven e il St. George's 
Hospital di Londra su progetti finanziati dalla Fondazione Nazionale per Ia Scienza, Ricerca 
Universitaria e Sviluppo Tecnologico della Repubblica di Croazia e dalla ditta Medtronic. AlIa fine 
del 2009 ha chiesto l'am10 di proroga per poter condurre ulteriori misure e Ie relative analisi. 
La principale attivita di ricerca svolta ha riguardato 10 studio dell'elettrostin10lazione cardiaca. In 
particolare nei primi due anni si e concentrato sulla modellizzazione del funzionamento 
elettromeccanico del muscolo cardiaeo al fine di individuare nuove e pili iill10vative terapie 
nell'ambito della resineronizzazione eardiaca (0 elettrostimolazione biventricolare) che si e 
dimostrata potenzialnlente utile nel miglioramento dei sintomi e della funzione della pompa 
cardiaca. Nel primo anne si e focalizzato sulla simulazione presentata da Kerckhoffs ed in 
collaborazione con Prof. Bart Bijnens (KU Leuven, Belgio) ha integrato e valutato nella prassi 
c1inica il modello inserendovi nuovi aspetti del movimento anomalo del setto cardiaco. AlIa fine del 
primo anno, la Medtronic ha interrotto la ricerca. 
II dottorando ha quindi nl0dificato, nel secondo anne di ricerca, il suo obiettivo adattando e 
applicando il modello unidimensionale autoadattativo delI'intero sistema cardiovascolare, basato su 
quanto descritto nel lavoro di Arts, al caso dell'ipertensione arteriosa polmonare osservabile nei 
pazienti con anelnia falciforme. Questa seconda ricerca e stata sviluppata insieme ad un gruppo di 
cardiologi e pneumologi del St. George's Hospital di Londra dove sono stati raccolti i dati da 
pazienti pediatrici di origine centro-africana dove la malattia e pili frequente. Prendendo in 
considerazione la geometria cardiaca e i paranletri dell' emodinamica specifici di ogni paziente, il 
dottorando ha ottenuto dei risultati quantitativi che rispecchiano bene il meccanismo dell' anemia 
falcifolme. Purtroppo gli errori relativi delle misure ecoeardiografiche di interesse sono risultati 
eccessivi, impedendo l'uso del modello nella prassi clinica. 
Negli ultimi due am1i il dottorando ha condotto una nuova ricerca basata su una serie di brevetti 
amerieani del dr. Bozidar Ferek-Petri6. Lo scopo del progetto estate quello di costruire un sensore 
delle contrazioni cardiache compatibile con tutti gli elettrocateteri in commercio indipendentemente 
dal tipo e dal produttore al fine di utilizzarlo per il rilevanlento anche precoce e la differenziazione 
di diversi tipi di aritmie e di ritmi cardiaci con una precisione maggiore rispetto i sistemi esistenti. II 
dottorando ha analizzato Ie caratteristiche in alta frequenza di una serie di elettroeateteri di diversa 
forma, costnlzione dei conduttori e con diversi tipi di isolamento ed ha ideato e realizzato tre nuovi 
tipi di sensori emodinamici per il rilevan1ento delle contrazioni cardiache. Tali sensori sono stati 
testati su un eerto numero di pazienti nei Dipartimenti di Cardiologia a Zagabria e Fiume. Inoltre 
alcuni elettrocateteri speciali sono stati impiantati anche su alcune pecore alla Facolta di Veterinaria 
di Zagabria in modo da poter effettuare sia misure acute che croniche al fine di avere informazioni 
sulla stabilita del sistema in vivo anche su tempi Inedio-lunghi. Trattandosi di procedure invasive, e 
state necessario ottenere gli opportuni pemlessi dalle Commissioni etiche dei Centri Clinici e dai 
Ministeri della Sanita edell'Agricoltura Croati, che hanno compoliato ritardi nella ricerca oltre 
quelli prodotti dal fatto che si e trattato di realizzare strumenti da utilizzare in sala operatoria che 
dovevano quindi rispettare anche precise regole sulla sterilizzazione. 
~~-.~.~ {\i 
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L'attivita scientifica del dottorando eattestata da 3 articoli inviati a riviste intemazionali, e da 4 
articoli pres ent ati a congressi intemazionali e nazionali. Altri lavori da inviare a rivista 
intemazionale sono attualmente in preparazione. Una parte dei risultati so no stati presentati a 
convegni intemi alIa Medtronic in quanta coperti da segreto industriale. 
11 dottorando ha paliecipato a numerosi corsi di formazione ed ha tenuto oltre 30 sessioni didattiche 
sull' elettrostimolazione per i cardiologi, cardiochirurghi e personale tecnico di ospedali in Serbia, 
Slovenia, Croazia, Bosnia ed Erzegovina, Kosovo e Albania. 
II dottorando si e dedicato all' attivita di ricerca con impegno e autononlia, conseguendo risultati 
originali testimoniati dal personale contributo alle pubblicazioni elencate, sviluppando diretti 
rapporti di collaborazione con enti estemi raggiungendo un discreto livello di maturazione 
scientifica. 
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